TW200948861A - Liquid crystal aligning agent and liquid crystal display element - Google Patents

Liquid crystal aligning agent and liquid crystal display element Download PDF

Info

Publication number
TW200948861A
TW200948861A TW098109439A TW98109439A TW200948861A TW 200948861 A TW200948861 A TW 200948861A TW 098109439 A TW098109439 A TW 098109439A TW 98109439 A TW98109439 A TW 98109439A TW 200948861 A TW200948861 A TW 200948861A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
group
crystal alignment
formula
polymer
Prior art date
Application number
TW098109439A
Other languages
Chinese (zh)
Other versions
TWI453234B (en
Inventor
Shouichi Nakata
Eiji Hayashi
Original Assignee
Jsr Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jsr Corp filed Critical Jsr Corp
Publication of TW200948861A publication Critical patent/TW200948861A/en
Application granted granted Critical
Publication of TWI453234B publication Critical patent/TWI453234B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nonlinear Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Mathematical Physics (AREA)
  • Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Liquid Crystal (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

The present invention relates to a liquid crystal aligning agent and liquid crystal display element. The said liquid crystal aligning agent has excellent printing property even face to the substrate having difference in level, and forms liquid crystal alignment film which could stability express high pre-tilting angle. The said liquid crystal aligning agent comprises at least one polymer selected from the group consisting of follows; the said group is made of polyamic acid and the imiding polymer form by cyclodehydration of the said polyamic acid; the said polyamic acid is made of diamine and tetracarboxylic dianhydrate. The said diamine comprises 3, 5-diaminobenzoic cholestanyl ester as the representative specific compound and the compound represented by the following formula (B-1) as the representative specific compound.

Description

200948861 六、發明說明: 【發明所屬之技術領域】 本發明關於液晶配向劑和液晶顯示元件。 【先前技術】 目前,已知具有TN(扭曲向列)型或STN(超扭曲向列) 型液晶胞的液晶顯示元件,其在通過透明導電膜於表面上 形成了含聚醯胺酸或醯亞胺聚合物的液晶配向膜的兩塊基 板之間,形成具有正介電各向異性的向列型液晶的層,構 ❹ 成夾層結構,上述液晶分子的長軸在基板之間連續地扭曲 9(Γ以上。通過TFT驅動而使該TN型液晶顯示元件工作的 所謂的TFT液晶顯示面板替代以前的陰極射線管已廣泛普 及。這些液晶顯示元件中液晶的配向,通常由經過打磨處 理等賦予了液晶分子配向能的液晶配向膜實現。此外,作 爲與上述不同的液晶顯示元件,已知具備使具有負介電各 向異性的液晶分子在基板上垂直配向的垂直配向(Vertical Alignment)型液晶胞的液晶顯示元件。在這種液晶顯示元 〇 件中,液晶分子的配向控制,通常也通過由含聚醯胺酸、 醯亞胺聚合物等聚合物的液晶配向劑形成的、以這些聚合 物作爲主要成分的液晶配向膜產生。 近年來,爲了得到更鮮明、優美的圖像的目的,液晶 顯示元件在向高開口率化、高精密化發展。爲此,在TN 型液晶顯示元件中,需要能夠穩定地產生比以前更大的預 傾角的液晶配向膜。另外,視角優良的垂直配向型液晶顯 示元件,大多用於監視器用途、TV用途,而其必須具有能 夠穩定地產生約90°預傾角的液晶配向膜。液晶配向膜通常 200948861 通過採用印刷機將液晶配向劑塗敷於基板上,再進行烘焙 而形成,而若形成的液晶配向膜中存在膜厚度不均勻,則 具有這種液晶配向膜的液晶顯示元件顯示的圖像中會出現 不勻。因此需要塗敷性(特別是印刷性)優良的液晶配向劑。 在以聚合物作爲主要成分的液晶配向膜中,已知預傾 角取決於聚合物所具有的取代基。例如,在專利文獻1中, 揭示了以採用側鏈上具有1-十八烷氧基-2,4-二胺基苯這種 大體積取代基的單體(以下稱產生預傾角的單體)製得的聚 φ 合物作爲主要成分的液晶配向膜將產生預傾角。但是由於 爲了用1-十八烷氧基-2,4-二胺基苯使其穩定地產生足夠大 的預傾角,必須大量地使用該化合物,因此含有所得的聚 合物的液晶配向劑印刷性不夠好。因此,出現具有用其形 成的液晶配向膜的液晶顯示元件不能顯示優美圖像的問 另外,在專利文獻2中,揭示了包括4-(4-(4-正戊基環 己基)環己基-2,6-二氟苯基)氧基二氟甲基-1,3-苯二胺在內 G 的6種二胺,並記載了當在聚合物的合成時,相對於所用 二胺的總量使用90莫耳%這些二胺時,可以產生高預傾 角。但是含有用90莫耳%該二胺製得的聚合物的液晶配向 劑,其印刷性不夠好,具有用其形成的液晶配向膜的液晶 顯示元件,存在不能顯示優美圖像的問題。 這樣,以往液晶配向劑的印刷性與所形成的液晶配向 膜的產生預傾角的性能處於悖論的關係,因而在尋求兩者 並存。 在專利文獻3和4中,記載了含有採用具有甾體骨架 200948861 的特定二胺合成的聚醯胺酸或其醯亞胺化聚合物的液晶配 向劑。該技術可以看出具備較少用量的上述特定二胺即可 製得產生高預傾角的聚合物的能力’是採用含有這種聚合 物的液晶配向劑來實現印刷性與所形成的液晶配向膜的高 預傾角產生性能並存的優良技術。因此,具有用該液晶配 向劑形成的液晶配向膜的液晶顯示元件能夠顯示優美的圖 像,解決了上述現有技術的問題。 但是隨著動畫定影技術的發展,液晶顯示元件要求更 〇 精細更優美的顯示,即使高度活動的圖像在快速移動時也 必須能夠迅速且正確地回應。爲此,由於電學技術的問題, 存在基板上形成的級差不可避免地增大的趨勢,這種大級 差部分的印刷性的提高,正在成爲液晶配向劑新的重要課 題。 【專利文獻1】日本特開平6-136122號公報 【專利文獻2】日本特開2003-96034號公報 【專利文獻3】日本專利第2893671號說明書 ❹ 【專利文獻4】日本專利第3811985號說明書 【專利文獻5】日本特開平4-281427號公報 【專利文獻6】曰本特開2003-321490號公報 【專利文獻7】國際公開第04/052962號小冊子 【專利文獻8】國際公開第02/0 51909號小冊子 【專利文獻9】國際公開第02/051908號小冊子 【專利文獻1〇】日本特開平7-301805號公報 【專利文獻11】日本特開平8-012759號公報 【專利文獻12】日本特開平5-043687號公報 200948861 【專利文獻13】曰本特開平9-278724號公報 【專利文獻14】日本特開2002-327058號公報 【專利文獻15】日本特開平6·222366號公報 【專利文獻16】日本特開平6-281937號公報 【專利文獻17】日本特開平5-107544號公報 【非專利文獻 1】T. J. Scheffer, et. al.,J. Appl. Phys., Vol. 1 9,20 1 3 (1 9 80) 【發明内容】 〇 本發明是基於以上情況而作出的。 本發明的第一目的是提供即使對於級差大的基板也具 有優良的印刷性,並且可以形成能夠穩定地表現高預傾角 的液晶配向膜的液晶配向劑。 本發明的第二目的是提供能夠精細地進行優美的顯 示,並且即使在高度活動的圖像快速移動時也能夠正確地 對應的液晶顯示元件。 本發明者們爲了達到上述目的而進行了專心硏究,結 © 果達成了本發明。 即,本發明的上述目的和優點,第一,由一種液晶配 向劑達成,其包括從下述群組中選出的至少一種聚合物, 該群組由聚醯胺酸以及將該聚醯胺酸脫水閉環而製得的醯 亞胺化聚合物構成,該聚醯胺酸由二胺與四羧酸二酐反應 所製得,該二胺含有下述式(Α)表示的化合物和下述式(Β) 表示的化合物, 200948861200948861 VI. Description of the Invention: [Technical Field] The present invention relates to a liquid crystal alignment agent and a liquid crystal display element. [Prior Art] At present, a liquid crystal display element having a TN (Twisted Nematic) type or an STN (Super Twisted Nematic) type liquid crystal cell is known which forms a polyglycine or ruthenium on a surface thereof through a transparent conductive film. A layer of nematic liquid crystal having positive dielectric anisotropy is formed between the two substrates of the liquid crystal alignment film of the imine polymer, and is configured as a sandwich structure, and the long axis of the liquid crystal molecules is continuously twisted between the substrates. 9 (Γ). A so-called TFT liquid crystal display panel in which the TN type liquid crystal display element operates by TFT driving has been widely used in place of the conventional cathode ray tube. The alignment of liquid crystals in these liquid crystal display elements is usually imparted by sanding treatment or the like. A liquid crystal alignment film having a liquid crystal molecule alignment energy is realized. Further, as a liquid crystal display element different from the above, it is known to provide a vertical alignment type liquid crystal in which liquid crystal molecules having negative dielectric anisotropy are vertically aligned on a substrate. a liquid crystal display element of a cell. In such a liquid crystal display element, the alignment control of liquid crystal molecules is usually also carried out by a poly-proline-containing acid A liquid crystal alignment film formed of a liquid crystal alignment agent of a polymer such as a polymer and having such a polymer as a main component is produced. In recent years, in order to obtain a more vivid and beautiful image, the liquid crystal display element has a high aperture ratio. For this reason, in the TN type liquid crystal display device, a liquid crystal alignment film capable of stably generating a pretilt angle larger than before is required. In addition, a vertical alignment type liquid crystal display element having excellent viewing angle is mostly used for a monitor. For use, TV use, and it is necessary to have a liquid crystal alignment film capable of stably generating a pretilt angle of about 90. The liquid crystal alignment film is usually formed by applying a liquid crystal alignment agent to a substrate by a printing machine and baking it, and if it is baked, When the thickness of the liquid crystal alignment film formed is not uniform, unevenness may occur in an image displayed by a liquid crystal display element having such a liquid crystal alignment film. Therefore, a liquid crystal alignment agent excellent in coatability (particularly, printability) is required. In the liquid crystal alignment film having a polymer as a main component, it is known that the pretilt angle depends on the substituent which the polymer has. For example, in Patent Document 1, it is disclosed that a monomer having a bulky substituent having 1-octadecyloxy-2,4-diaminobenzene in a side chain (hereinafter referred to as a monomer having a pretilt angle) is used. The liquid crystal alignment film which has the obtained poly φ compound as a main component will produce a pretilt angle, but since it is stably produced with 1-octadecyloxy-2,4-diaminobenzene, a sufficiently large pretilt angle is obtained. Since the compound must be used in a large amount, the liquid crystal alignment agent containing the obtained polymer is not sufficiently printed. Therefore, the liquid crystal display element having the liquid crystal alignment film formed therewith cannot display a beautiful image. 2, which discloses 4-(4-(4-n-pentylcyclohexyl)cyclohexyl-2,6-difluorophenyl)oxydifluoromethyl-1,3-phenylenediamine Six kinds of diamines, and it is described that when 90% by mole of these diamines are used relative to the total amount of the diamine used in the synthesis of the polymer, a high pretilt angle can be produced. However, a liquid crystal alignment agent containing a polymer obtained by using 90 mol% of the diamine has a problem that printing property is not good enough, and a liquid crystal display element having a liquid crystal alignment film formed therefrom has a problem that a beautiful image cannot be displayed. As described above, the printability of the liquid crystal alignment agent and the performance of the pre-tilt angle of the formed liquid crystal alignment film are in a paradoxical relationship, and therefore both are sought to coexist. Patent Documents 3 and 4 disclose liquid crystal alignment agents containing polyaminic acid or a quinone imidized polymer having a specific diamine synthesis having a steroid skeleton 200948861. The technique can be seen that the ability to produce a polymer having a high pretilt angle with a small amount of the above specific diamine is achieved by using a liquid crystal alignment agent containing the polymer to achieve printability and formed liquid crystal alignment film. The high pretilt angle produces an excellent technique for coexistence of performance. Therefore, the liquid crystal display element having the liquid crystal alignment film formed using the liquid crystal alignment agent can display a beautiful image, and solves the above problems of the prior art. However, with the development of animation fixing technology, liquid crystal display elements require a finer and more beautiful display, and even highly moving images must be able to respond quickly and correctly when moving fast. For this reason, there is a tendency that the level difference formed on the substrate inevitably increases due to the problem of electrical technology, and the improvement of the printability of such a large-order difference portion is becoming a new important topic of the liquid crystal alignment agent. [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. [Patent Document 5] Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. Japanese Patent Laid-Open Publication No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. [Patent Document 17] Japanese Laid-Open Patent Publication No. Hei 5-170044 [Non-Patent Document 1] TJ Scheffer, et. al., J. Appl. Phys., Vol. 0 1 3 (1 9 80) [Description of the Invention] The present invention has been made based on the above circumstances. A first object of the present invention is to provide a liquid crystal alignment agent capable of stably exhibiting a high pretilt angle of a liquid crystal alignment film even if it has excellent printability for a substrate having a large step difference. A second object of the present invention is to provide a liquid crystal display element which is capable of finely performing beautiful display and which can correctly correspond even when a highly moving image is rapidly moved. The inventors of the present invention have intensively studied in order to achieve the above object, and have achieved the present invention. That is, the above objects and advantages of the present invention, first, achieved by a liquid crystal alignment agent comprising at least one polymer selected from the group consisting of polylysine and the polyamic acid a ruthenium-imided polymer obtained by dehydration ring closure, which is obtained by reacting a diamine with a tetracarboxylic dianhydride containing a compound represented by the following formula (Α) and the following formula (Β) Compound expressed, 200948861

(A) (式(A)中,A1表示單鍵、亞甲基、碳原子數爲2〜12 的伸烷基、氟代亞甲基或碳原子數爲2〜6的氟代伸烷基 A2 表示-〇-、-COO-、-OCO-、-NHCO-、-CONH-或-CO-, Ο A3表示具有甾體骨架的1價有機基團)。(A) (In the formula (A), A1 represents a single bond, a methylene group, an alkylene group having 2 to 12 carbon atoms, a fluoromethylene group or a fluoroalkylene group having 2 to 6 carbon atoms. A2 represents -〇-, -COO-, -OCO-, -NHCO-, -CONH- or -CO-, and ΟA3 represents a monovalent organic group having a steroid skeleton).

(B) (CH2)b1-B1—((CH2)b2-〇)b3-B2 (式(B)中,B1 爲-0-、-COO-、-OOC·、-CONH-或 -NHCO-,B2爲聯苯基、氰基聯苯基、氟代聯苯基、具有碳 原子數爲1〜32的烷基的(烷基環己基)苯基、具有碳原子 ® 數爲1〜32的烷氧基的烷氧基苄基、二烷氧基苯基或烷氧 基聯苯基、具有碳原子數爲1〜32的氟代烷氧基的氟代烷 氧基聯苯基或者碳原子數爲1〜32的烷基,bl和b3各自 爲〇或1,b2爲2〜22的整數)。 本發明的上述目的和優點,第二,由具有由上述液晶 配向劑形成的液晶配向膜的液晶顯示元件達成。 本發明的液晶配向劑,即使對於級差大的基板也具有 優良的印刷性,並且可以形成能夠穩定地表現高預傾角的 200948861 液晶配向膜。具有這種液晶配向膜的本發明液晶顯示元 件,能夠精細地進行優美的顯示,並且即使在高度活動的 圖像快速移動時也能夠正確地對應。 本發明的液晶顯示元件可以有效地用於各種裝置,例 如可適用於計算器、手錶、時鐘、行動電話、計數顯示面 板、文字處理器、個人電腦、液晶電視機等的顯示裝置。 【實施方式】 以下,對本發明進行具體說明。 © 本發明的液晶配向劑包括從下述群組中選出的至少一 種聚合物,該群組由聚醯胺酸以及將該聚醯胺酸脫水閉環 而製得的醯亞胺化聚合物構成,該聚醯胺酸由二胺與四羧 酸二酐反應所製得,該二胺含有上述式(A)表示的化合物和 上述式(B)表示的化合物。 <二胺> 上述聚醯胺酸的合成中所用的二胺,含有上述式(A) 表示的化合物和上述式(B)表示的化合物。 〇 作爲上述式(A)的A1中的碳原子數爲2〜12的伸烷 基,較佳係碳原子數爲2〜4的伸烷基’更佳係1,2-伸乙基、 1,3 -伸丙基、1,4 -伸丁基。作爲氟代亞甲基’較佳係-CF2-。 作爲碳原子數爲2〜6的氟代伸院基’較佳係碳原子數爲2 〜4的全氟伸烷基’更佳係1,2-全氟伸乙基、1,3-全氟伸丙 基、1,4 -全氟伸丁基。 作爲A2,較佳係-0 -。 A3中的甾體骨架’是指由環戊烷一全氫菲核構成的結 構或其碳-碳鍵中的一個或兩個以上改爲雙鍵的結構。作 200948861 爲具有這種留體骨架的1價有機基團,較佳係碳原子數爲 17〜40的基團。 《乍m ±述式(a)表示的化合物的具體例子,可以列舉例 如1-膽甾烯氧基甲基-2,4_二胺基苯、2-膽甾烯氧基乙基 -2,4-二胺基苯、3_膽甾烯氧基丙基-2,4_二胺基苯、4_膽甾 烯氧基丁基-2,4-二胺基苯、1_膽甾烯氧基甲基-3,5-二胺基 苯、2-膽甾烯氧基乙基-3,5_二胺基苯、3_膽甾烯氧基丙基 -3,5-二胺基苯、4-膽甾烯氧基丁基-3,5-二胺基苯、1-(1-膽 φ 甾烯氧基-1,1-二氟甲基)-2,4-二胺基苯、1-(2-膽甾烯氧基 -1,1,2,2-四氣乙基)_2,4-二胺基苯、1-(3-膽留燃氧基 •1,1,2,2,3,3-六氟丙基)_2,4-二胺基苯、1-(4-膽甾烯氧基 -1,1,2,2,3,3,4,4 -八氟丁基)-2,4 -二胺基苯、1-(1-膽甾烯氧 基-1,1-二氟甲基)-3,5-二胺基苯、1-(2-膽甾烯氧基-1,1,2,2-四氟乙基)-3,5-二胺基苯、1-(3-膽甾烯氧基-1,1,2,2,3,3-六 氟丙基)-3,5-二胺基苯、1-(4-膽甾烯氧基-1,1,2,2,3,3,4,4-八氟丁基)-3,5-二胺基苯、1-膽甾烷氧基甲基-2,4-二胺基 φ 苯、2-膽甾烷氧基乙基-2,4-二胺基苯、3-膽甾烷氧基丙基 -2,4-二胺基苯、4-膽甾烷氧基丁基·2,4-二胺基苯、1-膽甾 烷氧基甲基-3,5-二胺基苯、2-膽甾烷氧基乙基·3,5-二胺基 苯、3 -膽笛院氧基丙基-3,5· _•胺基苯、4 -膽笛院氧基丁基 ·3,5-二胺基苯、1-(1-膽甾烷氧基-1,1-二氟甲基)-2,4-二胺 基苯、1-(2-膽甾烷氧基-1,1,2,2-四氟乙基)-2,4-二胺基苯、 1-(3-膽笛烷氧基-1,1,2,2,3,3-六氟丙基)-2,4-二胺基苯、 1-(4-膽甾烷氧基-1,1,2,2,3,3,4,4-八氟丁基)-2,4-二胺基 苯、1-(1-膽甾烷氧基-1,1-二氟甲基)-3,5-二胺基苯、1-(2- -10- 200948861 膽甾烷氧基-1,1,2,2-四氟乙基)-3,5-二胺基苯、1-(3-膽甾烷 氧基-1,1,2,2,3,3-六氟丙基)-3,5-二胺基苯、1-(4-膽甾烷氧 基-1,1,2,2,3,3,4,4-八氟丁基)-3,5-二胺基苯、3-(2,4-二胺基 苯基甲氧基)-4,4-二甲基膽甾烷、3-(2-(2,4-二胺基苯基)乙 氧基)-4,4-二甲基膽甾烷、3-(3-(2,4-二胺基苯基)丙氧 基)-4,4-二甲基膽甾烷、3-(4-(2,4-二胺基苯基)丁氧基)-4,4-二甲基膽甾烷、3-(3,5-二胺基苯基甲氧基)-4,4-二甲基膽甾 烷、3-(2-(3,5-二胺基苯基)乙氧基)-4,4-二甲基膽甾烷、 ❹ 3-(3-(3,5-二胺基苯基)丙氧基)-4,4-二甲基膽甾烷、 3-(4-(3,5-二胺基苯基)丁氧基)-4,4-二甲基膽甾烷、 3-(1-(2,4-二胺基苯基)-1,1-二氟甲氧基)-4,4-二甲基膽甾 烷、3-(2-(2,4-二胺基苯基)-1,1,2,2-四氟乙氧基)-4,4-二甲 基膽甾烷、3-(3-(2,4-二胺基苯基)-1,1,2,2,3,3-六氟丙氧 基)-4,4-二甲基膽甾烷 、3-(4-(2,4-二胺基苯 基)-1,1,2,2,3,3,4,4-八氟丁氧基)-4,4-二甲基膽甾烷、 3-(1-(3,5-二胺基苯基)-1,1-二氟甲氧基)-4,4-二甲基膽甾 Q 烷、3-(2-(3,5-二胺基苯基)-1,1,2,2-四氟乙氧基)-4,4-二甲 基膽甾烷、3-(3-(3,5-二胺基苯基)-1,1,2,2,3,3-六氟丙氧 基)-4,4-二甲基膽甾烷 、3-(4-(3,5-二胺基苯 基)-1,1,2,2,3,3,4,4-八氟丁氧基)-4,4-二甲基膽甾烷、 3-(2,4 -二胺基苯基)甲氧基膽烷-24 -酸十六烷基酯、 3-(2-(2,4-二胺基苯基)乙氧基)膽烷-24-酸十六烷基酯、 3-(3-(2,4-二胺基苯基)丙氧基)膽烷-24-酸十六烷基酯、 3-(4-(2,4-二胺基苯基)丁氧基)膽烷-24-酸十六烷基酯、 3-(3,5 -二胺基苯基)甲氧基膽烷-24-酸十六烷基酯、 -11- 200948861 3-(2-(3,5-二胺基苯基)乙氧基)膽烷-24-酸十六烷基酯、 3-(3-(3,5-二胺基苯基)丙氧基)膽烷-24-酸十六烷基酯、 3-(4-(3,5-二胺基苯基)丁氧基)膽烷-24-酸十六烷基酯、 3-(1-(3,5-二胺基苯基)-1,1-二氟甲氧基)膽烷- 24-酸十六烷 基酯、3-(2-(3,5-二胺基苯基)-1,1,2,2-四氟乙氧基)膽烷-24· 酸十六烷基酯、3-(3-(3,5-二胺基苯基)-1,1,2,2,3,3-六氟丙 氧基)膽烷-24-酸十六烷基酯、3-(4-(3,5-二胺基苯 基)-1,1,2,2,3,3,4,4-八氟丁氧基)膽烷- 24-酸十六烷基酯、 ❹ 3-(3,5-二胺基苯基甲氧基)膽烷-24-酸十八烷基酯、 3-(2-(3,5-二胺基苯基)乙氧基)膽烷-24-酸十八烷基酯、 3-(3-(3,5-二胺基苯基)丙氧基)膽烷-24-酸十八烷基酯、 3-(4-(3,5-二胺基苯基)丁氧基)膽烷-24-酸十八烷基酯、 3-((3,5-二胺基苯基)-1,1-二氟甲氧基)膽烷-24-酸十八烷基 酯、3-(2-(3,5-二胺基苯基)-1,1,2,2-四氟乙氧基)膽烷-24-酸十八烷基酯、3-(3-(3,5-二胺基苯基)-1,1,2,2,3,3-六氟丙 氧基)膽烷-24-酸十八烷基酯或 3-(4-(3,5·二胺基苯 〇 基)-1,1,2,2,3,3,4,4-八氟丁氧基)膽烷-24-酸十八烷基酯、1- 膽甾烯氧基-2,4-二胺基苯、3,5-二胺基苯甲酸膽甾烯基 酯、1-膽甾烷氧基-2,4-二胺基苯、3,5-二胺基苯甲酸膽甾 烷基酯等。 其中,從能夠產生高的預傾角的角度出發,較佳係使 用由1-膽甾烯氧基甲基-2,4-二胺基苯、1-膽甾烯氧基甲基 -3,5-二胺基苯、1-(1-膽甾烯氧基-1,1-二氟甲基)-2,4-二胺 基苯、1-(1-膽甾烯氧基-1,1-二氟甲基)-3,5-二胺基苯、1-(1-膽甾烷氧基-1,1-二氟甲基)-2,4-二胺基苯、1-(1-膽甾烷氧 -12- 200948861 基·1,1-二氟甲基)-3,5-二胺基苯、3-(2,4-二胺基苯基甲氧 基)-4,4-二甲基膽甾烷、3-(1-(2,4-二胺基苯基)-1,1-二氟甲 氧基)·4,4-二甲基膽甾烷、3-(3,5-二胺基苯基甲氧基)-4,4-二甲基膽甾烷、3-(1-(3,5 -二胺基苯基)-1,1-二氟甲氧 基)-4,4-二甲基膽甾烷、3-((2,4-二胺基苯基)甲氧基)膽烷 -24-酸十六烷基酯、3-(1-(2,4-二胺基苯基)·1,1-二氟甲氧基) 膽烷-24-酸十六烷基酯、3-((3,5-二胺基苯基)甲氧基)膽烷 -24-酸十六烷基酯、3-(1-(3,5-二胺基苯基)-1,1·二氟甲氧基) 0 膽烷-24-酸十六烷基酯、3-(2,4-二胺基苯基甲氧基)膽烷 -24-酸十八烷基酯、3-(1-(2,4-二胺基苯基)-1,1-二氟甲氧基) 膽烷-24-酸十八烷基酯、3-(3,5-二胺基苯基甲氧基)膽烷 -24-酸十八烷基酯、3-(1-(3,5-二胺基苯基)-1,1-二氟甲氧基) 膽烷-24-酸十八烷基酯、1-膽甾烯氧基-2,4·二胺基苯、3,5-二胺基苯甲酸膽甾烯基酯、1-膽甾烷氧基-2,4-二胺基苯和 3,5-二胺基苯甲酸膽甾烷基酯構成的群組中選出的一種以 上。並且,從以較小的使用比例就能產生特別高的預傾角 〇 的角度出發,其中特佳係使用由1-膽甾烯氧基-2,4-二胺基 苯、3,5-二胺基苯甲酸膽甾烯基酯、1-膽甾烷氧基-2,4-二 胺基苯和3,5·二胺基苯甲酸膽甾烷基酯構成的群組中選出 的一種以上。 上述式(Α)表示的化合物,可以通過例如專利文獻5(日 本特開平4-28 1 427號公報)或專利文獻 6(日本特開 2003-3 2 1 490號公報)中記載的方法製得。 本發明的液晶配向劑,由於包含具有來自於上述式(Α) 表示的化合物的重複結構單元的聚合物,因而可以在不損 -13- 200948861 害印刷性的前提下形成顯示高預傾角表現性的液晶配向 膜。 作爲上述式(B)中的B1,較佳係爲-0-或-COO-*(其中, 帶有“ ”的鍵結臂與-((CH2)b2-)b3-B2鍵結),更佳係爲 -〇 _ 〇 B2的聯苯基、氰基聯苯基、氟代聯苯基和氟代烷基聯 苯基,分別較佳係在聯苯基的4位上與鍵 結,這些氰基、氟基和氟代烷基分別較佳係位於聯苯基的 0 4’位。(烷基環己基)苯基所具有的烷基環己基較佳係鍵結在 苯基的對位,烷基較佳係鍵結在環己基的4’位。烷氧基苄 基較佳爲單烷氧基苄基或二烷氧基苄基。此時,單烷氧基 苄基所具有的烷氧基較佳係鍵結在對位,二烷氧基苄基所 具有的烷氧基較佳係鍵結在3,5位。氟代烷氧基聯苯基所 具有的氟代烷氧基的碳原子數較佳爲1〜6。(烷基環己基) 苯基所具有的烷基和烷氧基苄基所具有的烷氧基的碳原子 數各自較佳爲5〜12。 φ 上述式(B)中的兩個氰基,較佳係相對於 -(CHObi-Bi-UCHOu- 0)b3-B2 位於 2,4 位或 3,5-位。 作爲上述式(B)表示的化合物的具體例子,可以列舉例 如下述式(B-1)〜(B— 22)各自表示的化合物。 -14- 200948861(B) (CH2)b1-B1—((CH2)b2-〇)b3-B2 (in the formula (B), B1 is -0-, -COO-, -OOC·, -CONH- or -NHCO-, B2 is a biphenyl group, a cyanobiphenyl group, a fluorobiphenyl group, an (alkylcyclohexyl)phenyl group having an alkyl group having 1 to 32 carbon atoms, and an alkane having a carbon atom number of 1 to 32. An alkoxybenzyl group of a oxy group, a dialkoxyphenyl group or an alkoxybiphenyl group, a fluoroalkoxybiphenyl group having a fluoroalkoxy group having 1 to 32 carbon atoms or a carbon number It is an alkyl group of 1 to 32, and each of bl and b3 is 〇 or 1, and b2 is an integer of 2 to 22). The above objects and advantages of the present invention, and secondly, are achieved by a liquid crystal display element having a liquid crystal alignment film formed of the above liquid crystal alignment agent. The liquid crystal alignment agent of the present invention has excellent printability even for a substrate having a large step difference, and can form a 200948861 liquid crystal alignment film capable of stably exhibiting a high pretilt angle. The liquid crystal display element of the present invention having such a liquid crystal alignment film is capable of finely performing beautiful display and can correctly correspond even when a highly moving image is rapidly moved. The liquid crystal display element of the present invention can be effectively used for various devices, for example, display devices applicable to calculators, watches, clocks, mobile phones, counting display panels, word processors, personal computers, liquid crystal televisions, and the like. [Embodiment] Hereinafter, the present invention will be specifically described. The liquid crystal alignment agent of the present invention comprises at least one polymer selected from the group consisting of polylysine and a ruthenium-imided polymer obtained by dehydration of the polyglycine. The polyamic acid is obtained by reacting a diamine with a tetracarboxylic dianhydride containing the compound represented by the above formula (A) and a compound represented by the above formula (B). <Diamine> The diamine used in the synthesis of the above polyamic acid contains the compound represented by the above formula (A) and the compound represented by the above formula (B). 〇 is an alkylene group having 2 to 12 carbon atoms in A1 of the above formula (A), preferably an alkylene group having 2 to 4 carbon atoms. More preferably 1,2-ethylidene, 1 , 3 - propyl, 1,4 - butyl. The fluoromethylene group is preferably -CF2-. The fluororetinyl group having a carbon number of 2 to 6 is preferably a perfluoroalkylene group having a carbon number of 2 to 4, more preferably a 1,2-perfluoroextended ethyl group or a 1,3-allyl group. Fluoride propyl, 1,4-perfluorobutylene. As A2, it is preferably -0. The steroid skeleton ' in A3' means a structure composed of a cyclopentane-perhydrophenanthrene nucleus or a structure in which one or two or more of the carbon-carbon bonds are changed to a double bond. 200948861 is a monovalent organic group having such a skeleton, and is preferably a group having 17 to 40 carbon atoms. Specific examples of the compound represented by the formula (a) include, for example, 1-cholestyloxymethyl-2,4-diaminobenzene and 2-cholestyloxyethyl-2. 4-diaminobenzene, 3_cholestyloxypropyl-2,4-diaminobenzene, 4_cholestyloxybutyl-2,4-diaminobenzene, 1-cholestene Oxymethyl-3,5-diaminobenzene, 2-cholesteneoxyethyl-3,5-diaminobenzene, 3-cholestyloxypropyl-3,5-diamino Benzene, 4-cholesteneoxybutyl-3,5-diaminobenzene, 1-(1-cholestene-deceneoxy-1,1-difluoromethyl)-2,4-diamino Benzene, 1-(2-cholestenyloxy-1,1,2,2-tetrahydroethyl)-2,4-diaminobenzene, 1-(3-cholestyloxyoxyl-1,1, 2,2,3,3-hexafluoropropyl) 2,4-diaminobenzene, 1-(4-cholesteneoxy-1,1,2,2,3,3,4,4 -8 Fluorobutyl)-2,4-diaminobenzene, 1-(1-cholestenyloxy-1,1-difluoromethyl)-3,5-diaminobenzene, 1-(2-biliary Terpeneoxy-1,1,2,2-tetrafluoroethyl)-3,5-diaminobenzene, 1-(3-cholesteneoxy-1,1,2,2,3,3 -hexafluoropropyl)-3,5-diaminobenzene, 1-(4-cholestrenyloxy-1,1,2,2,3,3,4,4-octafluorobutyl)-3 , 5-diaminobenzene, 1-biliary Oxymethyl-2,4-diamino φ benzene, 2-cholestyloxyethyl-2,4-diaminobenzene, 3-cholestyloxypropyl-2,4-diamine Benzobenzene, 4-cholestyloxybutyl 2,4-diaminobenzene, 1-cholestyloxymethyl-3,5-diaminobenzene, 2-cholestyloxyethyl · 3,5-Diaminobenzene, 3-Bile oxypropyl-3,5· _•Aminobenzene, 4-Bile oxybutyl-3,5-diaminobenzene, 1 -(1-cholestyloxy-1,1-difluoromethyl)-2,4-diaminobenzene, 1-(2-cholestyloxy-1,1,2,2-tetrafluoro Ethyl)-2,4-diaminobenzene, 1-(3-cholestyroxy-1,1,2,2,3,3-hexafluoropropyl)-2,4-diaminobenzene , 1-(4-cholestyloxy-1,1,2,2,3,3,4,4-octafluorobutyl)-2,4-diaminobenzene, 1-(1-cholesteryl) Alkoxy-1,1-difluoromethyl)-3,5-diaminobenzene, 1-(2- -10- 200948861 cholestyloxy-1,1,2,2-tetrafluoroethyl -3,5-diaminobenzene, 1-(3-cholestyloxy-1,1,2,2,3,3-hexafluoropropyl)-3,5-diaminobenzene, 1 -(4-cholestyloxy-1,1,2,2,3,3,4,4-octafluorobutyl)-3,5-diaminobenzene, 3-(2,4-diamine Phenyl methoxy)-4,4-dimethylcholestane, 3-(2-(2,4-diamine) Phenyl)ethoxy)-4,4-dimethylcholestane, 3-(3-(2,4-diaminophenyl)propoxy)-4,4-dimethylcholyl Alkane, 3-(4-(2,4-diaminophenyl)butoxy)-4,4-dimethylcholestane, 3-(3,5-diaminophenylmethoxy) -4,4-dimethylcholestane, 3-(2-(3,5-diaminophenyl)ethoxy)-4,4-dimethylcholestane, ❹ 3-(3- (3,5-Diaminophenyl)propoxy)-4,4-dimethylcholestane, 3-(4-(3,5-diaminophenyl)butoxy)-4, 4-dimethylcholestane, 3-(1-(2,4-diaminophenyl)-1,1-difluoromethoxy)-4,4-dimethylcholestane, 3- (2-(2,4-Diaminophenyl)-1,1,2,2-tetrafluoroethoxy)-4,4-dimethylcholestane, 3-(3-(2,4) -diaminophenyl)-1,1,2,2,3,3-hexafluoropropoxy)-4,4-dimethylcholestane, 3-(4-(2,4-diamine) Phenyl)-1,1,2,2,3,3,4,4-octafluorobutoxy)-4,4-dimethylcholestane, 3-(1-(3,5-di) Aminophenyl)-1,1-difluoromethoxy)-4,4-dimethylcholestyl Q-, 3-(2-(3,5-diaminophenyl)-1,1, 2,2-tetrafluoroethoxy)-4,4-dimethylcholestane, 3-(3-(3,5-diaminophenyl) -1,1,2,2,3,3-hexafluoropropoxy)-4,4-dimethylcholestane, 3-(4-(3,5-diaminophenyl)-1, 1,2,2,3,3,4,4-octafluorobutoxy)-4,4-dimethylcholestane, 3-(2,4-diaminophenyl)methoxycholane -24 - cetyl acid ester, cetyl 3-(2-(2,4-diaminophenyl)ethoxy)cholane-24-ate, 3-(3-(2, 4-Diaminophenyl)propoxy)cholane-24-acid cetyl ester, 3-(4-(2,4-diaminophenyl)butoxy)cholane-24-acid Cetyl ester, cetyl 3-(3,5-diaminophenyl)methoxycholane-24-ate, -11- 200948861 3-(2-(3,5-diamine) Phenyl phenyl) ethoxy) cetyl-24-acid cetyl ester, 3-(3-(3,5-diaminophenyl)propoxy)cholane-24-acid cetyl Ester, cetyl 3-(4-(3,5-diaminophenyl)butoxy)cholane-24-ate, 3-(1-(3,5-diaminophenyl) -1,1-difluoromethoxy)cholane-hexadecyl hexadecyl ester, 3-(2-(3,5-diaminophenyl)-1,1,2,2-tetrafluoro Ethoxy)cholane-24·hexadecyl acid, 3-(3-(3,5-diaminophenyl)-1,1,2,2,3,3-hexafluoropropoxy Cholenet-24- Cetyl acid ester, 3-(4-(3,5-diaminophenyl)-1,1,2,2,3,3,4,4-octafluorobutoxy)cholane - 24 - cetyl acid ester, octadecyl 3-(3,5-diaminophenylmethoxy)cholane-24-ate, 3-(2-(3,5-diamino) Phenyl)ethoxy)cholene-24-octadecyl ester, 3-(3-(3,5-diaminophenyl)propoxy)cholane-24-octadecyl ester , 3-(4-(3,5-diaminophenyl)butoxy)cholane-24-octadecyl ester, 3-((3,5-diaminophenyl)-1, 1-Difluoromethoxy)cholane-24-acid octadecyl ester, 3-(2-(3,5-diaminophenyl)-1,1,2,2-tetrafluoroethoxy Cholecylate-24-octadecyl ester, 3-(3-(3,5-diaminophenyl)-1,1,2,2,3,3-hexafluoropropoxy)cholane -24-octadecyl acid ester or 3-(4-(3,5·diaminophenylphenyl)-1,1,2,2,3,3,4,4-octafluorobutoxy) Cholecylate-24-octadecyl ester, 1-cholesteneoxy-2,4-diaminobenzene, 3,5-diaminobenzoic acid cholesteryl ester, 1-cholestyloxy Base-2,4-diaminobenzene, cholesteryl 3,5-diaminobenzoate, and the like. Among them, from the viewpoint of being able to produce a high pretilt angle, it is preferred to use 1-cholestenoxymethyl-2,4-diaminobenzene, 1-cholestenoxymethyl-3,5. -diaminobenzene, 1-(1-cholestenyloxy-1,1-difluoromethyl)-2,4-diaminobenzene, 1-(1-cholesteneoxy-1,1 -difluoromethyl)-3,5-diaminobenzene, 1-(1-cholestyloxy-1,1-difluoromethyl)-2,4-diaminobenzene, 1-(1 -cholestaneoxy-12- 200948861 base · 1,1-difluoromethyl)-3,5-diaminobenzene, 3-(2,4-diaminophenylmethoxy)-4,4 - dimethylcholestane, 3-(1-(2,4-diaminophenyl)-1,1-difluoromethoxy)·4,4-dimethylcholestane, 3-( 3,5-Diaminophenylmethoxy)-4,4-dimethylcholestane, 3-(1-(3,5-diaminophenyl)-1,1-difluoromethoxy -4,4-dimethylcholestane, 3-((2,4-diaminophenyl)methoxy)cholane-24-acid cetyl ester, 3-(1-( 2,4-Diaminophenyl)·1,1-difluoromethoxy) Cetyl-24-acid cetyl ester, 3-((3,5-diaminophenyl)methoxy Cetyl-24-acid cetyl ester, 3-(1-(3,5-diaminophenyl)-1,1·difluoromethoxy) 0 Alkane-24-acid cetyl ester, 3-(2,4-diaminophenylmethoxy)cholane-24-octadecyl ester, 3-(1-(2,4-di) Aminophenyl)-1,1-difluoromethoxy) octadec-24-octadecanoate, 3-(3,5-diaminophenylmethoxy)cholane-24-acid Octadecyl ester, 3-(1-(3,5-diaminophenyl)-1,1-difluoromethoxy) cholane-24-octadecyl ester, 1-cholestene Oxy-2,4·diaminobenzene, cholesteryl 3,5-diaminobenzoate, 1-cholestyloxy-2,4-diaminobenzene and 3,5-diamine One or more selected from the group consisting of cholesteryl benzoate. Moreover, from the viewpoint of producing a particularly high pretilt angle 以 with a small use ratio, the use of 1-cholesteneoxy-2,4-diaminobenzene, 3,5-di is particularly preferred. One or more selected from the group consisting of cholesteryl aminobenzoic acid ester, 1-cholestyloxy-2,4-diaminobenzene, and cholesteryl 3,5-diaminobenzoic acid . The compound represented by the above formula (Α) can be obtained, for example, by the method described in Patent Document 5 (Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. . Since the liquid crystal alignment agent of the present invention contains a polymer having a repeating structural unit derived from the compound represented by the above formula (Α), it can be formed to exhibit high pretilt expression without impairing the printability of -13 to 200948861. Liquid crystal alignment film. As B1 in the above formula (B), it is preferably -0- or -COO-* (wherein the bonding arm with " " and -((CH2)b2-)b3-B2 bond), Preferably, the biphenyl group, the cyanobiphenyl group, the fluorobiphenyl group and the fluoroalkyl biphenyl group of 〇B2 are preferably bonded to the 4-position of the biphenyl group. The cyano group, the fluoro group and the fluoroalkyl group are preferably each located at the 0 4' position of the biphenyl group. The alkylcyclohexyl group of the (alkylcyclohexyl)phenyl group is preferably bonded to the para position of the phenyl group, and the alkyl group is preferably bonded to the 4' position of the cyclohexyl group. The alkoxybenzyl group is preferably a monoalkoxybenzyl group or a dialkoxybenzyl group. In this case, the alkoxy group of the monoalkoxybenzyl group is preferably bonded to the para position, and the alkoxy group of the dialkoxybenzyl group is preferably bonded to the 3,5 position. The fluoroalkoxy group of the fluoroalkoxybiphenyl group preferably has 1 to 6 carbon atoms. The alkyl group of the (alkylcyclohexyl)phenyl group and the alkoxy group of the alkoxybenzyl group each preferably have 5 to 12 carbon atoms. φ The two cyano groups in the above formula (B) are preferably at the 2, 4 or 3, 5 position relative to -(CHObi-Bi-UCHOu- 0)b3-B2. Specific examples of the compound represented by the above formula (B) include compounds represented by the following formulas (B-1) to (B-22). -14- 200948861

(Β·6) 200948861(Β·6) 200948861

(B-12)(B-12)

(B-13)(B-13)

(B-14) -16 200948861(B-14) -16 200948861

❹ h2n_^^〇^^0~c7H15 NH2 (B-18)❹ h2n_^^〇^^0~c7H15 NH2 (B-18)

上述式(B)表示的化合物可以採用例如專利文獻7〜 13(國際公開第04/052962號小冊子、國際公開第02/05 1 909 -17- 200948861 號小冊子、國際公開第02/0 51908號小冊子、日本特開平 7-30 1 805號公報、日本特開平8-01 2759號公報、特開平 5-043687號公報和日本特開平9-278724號公報)中所記載 的方法合成。 本發明液晶配向劑由於包含具有來自於上述式(B)表 示的化合物的結構單元聚合物,因而具有優良的印刷性。 作爲上述聚醯胺酸的合成中所使用的二胺,可以僅使 用上述式(A)表示的化合物和上述式(B)表示的化合物’或 0 者除了上述式(A)表示的化合物和上述式(B)表示的化合物 以外還可以與其他二胺倂用。 作爲這裏可以使用的其他二胺’可以列舉例如對苯二 胺、間苯二胺、4,4,-二胺基二苯基甲烷、4,4’-二胺基二苯 基乙烷、4,4,-二胺基二苯基硫醚、4,4,-二胺基二苯基颯、 3,3,-二甲基-4,4,-二胺基聯苯、4,4,-二胺基苯甲醯苯胺、 4,4’-二胺基二苯醚、1,5 -二胺基萘、5 -胺基-1-(4’-胺基苯 基)-1,3,3-三甲基茚滿、6-胺基-1-(4胺基苯基)-1,3,3-三甲 0 基茚滿、3,4,-二胺基二苯基醚、3,3’-二胺基二苯酮、3,4’-二胺基二苯酮、4,4,-二胺基二苯酮、2,2-二[4-(4-胺基苯氧 基)苯基]丙烷、2,2-二[4-(4-胺基苯氧基)苯基]六氟丙院、 2,2-二(4-胺基苯基)六氟丙烷、二[4-(4-胺基苯氧基)苯基] 碾、1,4-二(4-胺基苯氧基)苯、1,3-二(4-胺基苯氧基)苯、 1,3-二(3-胺基苯氧基)苯、9,9-二(4-胺基苯基)-1〇_氫蒽、 2,7-二胺基莽、9,9-二(4-胺基苯基)弗、2,2,,5,5,-四氯_4,4’-二胺基聯苯、2,2,-二氯-4,4,-二胺基_5,5’·二甲氧基聯苯、 3,3’-二甲氧基-4,4,-二胺基聯苯、4,4’-(對亞苯基二異伸丙 • 18 - 200948861 基)二苯胺、4,4’-(間亞苯基二異伸丙基)二苯胺、2,2,-二 [4-(4-胺基-2-三氟甲基苯氧基)苯基]六氟丙烷、4,4,-二胺 基-2,2’-二(三氟甲基)聯苯、4,4’-二胺基-2,2’-二甲基聯苯 或4,4’-二[(4-胺基-2-三氟甲基)苯氧基]-八氟聯苯等芳香 族二胺化合物; 間苯二甲胺、1, 3 -丙二胺、丁二胺、戊二胺、己二胺、 庚二胺、辛二胺、壬二胺、1,4-二胺基環己烷、異佛爾酮 二胺、四氫二環戊二烯二胺、六氫-4,7-亞甲基茚二亞甲基 φ 二胺、三環[6.2.1.02,7]十一碳烯二甲二胺、4,4,-亞甲基二 (環己胺)等脂肪族或脂環式二胺化合物; 2,3-二胺基吡啶、2,6-二胺基吡啶、3,4-二胺基吡啶、 2.4- 二胺基嘧啶、5,6-二胺基-2,3-二氰基吡畊、5,6-二胺基 -2,4-二羥基嘧啶、2,4-二胺基-6-二甲胺基-1,3,5·三阱、1,4-二(3-胺基丙基)呱阱、2,4 -二胺基-6-異丙氧基-1,3,5-三阱、 2.4- 二胺基-6-甲氧基-1,3,5-三阱、2,4-二胺基-6-苯基 -1,3,5-三畊、2,4·二胺基-6-甲基-s-三畊、2,4-二胺基-1,3,5- Φ 三畊、4,6-二胺基-2-乙烯基-s-三哄、2,4-二胺基-5-苯基噻 唑、2,6-二胺基嘌呤、5,6-二胺基-1,3-二甲基尿嘧啶、3,5-二胺基-1,2,4-三唑、6,9-二胺基-2-乙氧基吖啶乳酸酯、3,8-二胺基-6-苯基菲啶、1,4-二胺基呱畊、3,6-二胺基吖啶、 二(4-胺基苯基)苯基胺、下述式(D — I)表示的化合物,The compound represented by the above formula (B) can be, for example, patent documents 7 to 13 (International Publication No. 04/052962 pamphlet, International Publication No. 02/05 1 909 -17-200948861 pamphlet, International Publication No. 02/0 51908 pamphlet The method described in the method described in Japanese Unexamined Patent Publication No. Hei No. Hei. No. Hei. No. Hei. No. Hei. The liquid crystal alignment agent of the present invention has excellent printability because it contains a structural unit polymer having a compound derived from the above formula (B). As the diamine used in the synthesis of the above polyamic acid, the compound represented by the above formula (A) and the compound represented by the above formula (B) or the compound represented by the above formula (A) and the above may be used. In addition to the compound represented by the formula (B), it may be used together with other diamines. As other diamines which can be used herein, for example, p-phenylenediamine, m-phenylenediamine, 4,4,-diaminodiphenylmethane, 4,4'-diaminodiphenylethane, 4 ,4,-Diaminodiphenyl sulfide, 4,4,-diaminodiphenylphosphonium, 3,3,-dimethyl-4,4,-diaminobiphenyl, 4,4, -diaminobenzimidamide, 4,4'-diaminodiphenyl ether, 1,5-diaminonaphthalene, 5-amino-1-(4'-aminophenyl)-1,3 ,3-trimethylindan, 6-amino-1-(4-aminophenyl)-1,3,3-trimethylindan, 3,4,-diaminodiphenyl ether, 3 , 3'-diaminobenzophenone, 3,4'-diaminobenzophenone, 4,4,-diaminobenzophenone, 2,2-bis[4-(4-aminophenoxyl) Phenyl]propane, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, two [4-(4-Aminophenoxy)phenyl] milled, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1 , 3-bis(3-aminophenoxy)benzene, 9,9-bis(4-aminophenyl)-1〇-hydroquinone, 2,7-diaminopurine, 9,9-di ( 4-aminophenyl), 2, 2, 5, 5 ,-tetrachloro-4,4'-diaminobiphenyl, 2,2,-dichloro-4,4,-diamino-5,5'dimethoxybiphenyl, 3,3'- Dimethoxy-4,4,-diaminobiphenyl, 4,4'-(p-phenylene diisopropanoid • 18 - 200948861 yl)diphenylamine, 4,4'-(m-phenylene di Isopropyl)diphenylamine, 2,2,-bis[4-(4-amino-2-trifluoromethylphenoxy)phenyl]hexafluoropropane, 4,4,-diamino-2 , 2'-bis(trifluoromethyl)biphenyl, 4,4'-diamino-2,2'-dimethylbiphenyl or 4,4'-bis[(4-amino-2-yl) An aromatic diamine compound such as fluoromethyl)phenoxy]-octafluorobiphenyl; m-xylylenediamine, 1,3-propylenediamine, butanediamine, pentanediamine, hexamethylenediamine, heptanediamine, Octanediamine, decanediamine, 1,4-diaminocyclohexane, isophoronediamine, tetrahydrodicyclopentadiene diamine, hexahydro-4,7-methylene fluorene dimethylene An aliphatic or alicyclic diamine compound such as φ diamine, tricyclo[6.2.1.02,7]undecene dimethyldiamine, 4,4,-methylenebis(cyclohexylamine); 3-diaminopyridine, 2,6-diaminopyridine, 3,4-diaminopyridine, 2.4-diaminopyrimidine, 5,6-diamino-2,3-dicyanide Pyridin, 5,6-diamino-2,4-dihydroxypyrimidine, 2,4-diamino-6-dimethylamino-1,3,5·triple, 1,4-bis(3) -aminopropyl)oxime, 2,4-diamino-6-isopropoxy-1,3,5-tris, 2.4-diamino-6-methoxy-1,3,5 -Tri-trap, 2,4-diamino-6-phenyl-1,3,5-three tillage, 2,4·diamino-6-methyl-s-three tillage, 2,4-diamine Base-1,3,5- Φ three tillage, 4,6-diamino-2-vinyl-s-triazine, 2,4-diamino-5-phenylthiazole, 2,6-diamine Base, 5,6-diamino-1,3-dimethyluracil, 3,5-diamino-1,2,4-triazole, 6,9-diamino-2-ethoxy Acridine lactate, 3,8-diamino-6-phenylphenanthridine, 1,4-diamine hydrazine, 3,6-diaminoacridine, bis(4-aminophenyl) a phenylamine, a compound represented by the following formula (D-I),

(式(D — I)中,R1表示具有由吡啶、嘧啶、三畊、呱啶以及 -19- 200948861 呱畊構成的群組中選出的結構的1價有機基團’ χ1表示2 價的有機基團)、下述式(D— II)表示的化合物等分子內具有 兩個一級胺基以及該一級胺基以外的氮原子的二胺化合 物, η2 (D-Π) (式(D— II)中,R2表示具有由吡啶、嘧啶、三哄、呱 ® 啶以及呱畊構成的群組中選出的結構的2價有機基團,X2 分別表示2價的有機基團); 下述式(D-III)表示的化合物等二胺基有機矽氧烷, R3 R3 •nh2(In the formula (D-I), R1 represents a monovalent organic group having a structure selected from the group consisting of pyridine, pyrimidine, tri-farming, acridine, and -19-200948861 sorghum' χ1 represents a 2-valent organic a group, a compound represented by the following formula (D-II), or a diamine compound having two primary amino groups in the molecule and a nitrogen atom other than the primary amine group, η2 (D-Π) (Formula D-II) In the formula, R2 represents a divalent organic group having a structure selected from the group consisting of pyridine, pyrimidine, triterpene, fluorene®, and argon, and X2 represents a divalent organic group, respectively; a compound such as D-III), such as a diamine organooxane, R3 R3 • nh2

Si — _(〇—s丨)(CH^-f R3 R3 (D-III) (式(D — III)中,R3分別表示碳原子數爲〗〜i2的烴 基’存在的多個R3各自可以相同,也可以不同,p各自爲 1〜3的整數,q爲1〜20的整數); 下述式(D — 1)〜(D-7)各自表示的化合物等, -20- 200948861Si — _(〇—s丨)(CH^-f R3 R3 (D-III) (In the formula (D-III), each of R3 in which R3 represents a hydrocarbon group having a carbon number of ~i2, respectively] may be The same or different, each p is an integer of 1 to 3, and q is an integer of 1 to 20); a compound represented by the following formulas (D-1) to (D-7), -20-200948861

h2nH2n

o-(-c2h4-oO-(-c2h4-o

(D-4) h2n-(D-4) h2n-

NHz (D-5)NHz (D-5)

(式(D — 4)中的y爲2〜12的整數,式(D-5的整數)。 這些其他二胺中,從合成聚醯胺酸時的 -5)中的z爲1 聚合反應性角 -21 - 200948861 度考慮,較佳係含有由對苯二胺、4,4’-二胺基二苯甲烷、 4,4’-二胺基二苯硫醚、1,5-二胺基萘、2,7-二胺基蒹、4,4,_ —基一本基酸、2,2 - —*[4-(4-胺基苯氧基)苯基]丙院、9,9· 二(4-胺基苯基)莽、2,2-二[4-(4-胺基苯氧基)苯基]六氟丙 烷、2,2-二(4-胺基苯基)六氟丙烷、4,4,-(對亞苯基二異伸丙 基)二苯胺、4,4’-(間亞苯基二異伸丙基)二苯胺、1,4-環己 烷二胺、4,4’-亞甲基二(環己胺)、1,4-二(4-胺基苯氧基)苯、 4,4’-二(4-胺基苯氧基)聯苯、4,4’-二胺基-2,2’-二(三氟甲基) ❹ 聯苯、4,4’-二胺基-2,2’-二甲基聯苯、2,6-二胺基啦陡、3,4-二胺基吡啶、2,4-二胺基嘧啶、3,6-二胺基吖啶、上述式(D -I)表示的化合物中的下述式(D - 8)表示的化合物、上述式 (D — II)表示的化合物中的下述式(D 一 9)表示的化合物、上 述式(D~ III)表示的化合物中的下述式(D - 1〇)表示的化合 物' 上述式(D — 6)表示的化合物和上述式(d - 7)表示的化合 物構成的群組中選出的至少一種(以下稱爲“其他特定二(wherein y in the formula (D-4) is an integer of 2 to 12, and an integer of the formula (D-5). Among these other diamines, z in the -5) from the synthesis of the poly-proline is 1 polymerization. Sex angle 21 - 200948861, preferably containing p-phenylenediamine, 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenyl sulfide, 1,5-diamine Naphthyl, 2,7-diaminopurine, 4,4, _-yl-based acid, 2,2 -*[4-(4-aminophenoxy)phenyl]propyl, 9, 9. Di(4-aminophenyl)anthracene, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl) Hexafluoropropane, 4,4,-(p-phenylene diiso-propyl)diphenylamine, 4,4'-(m-phenylene diisopropyl)diphenylamine, 1,4-cyclohexane Amine, 4,4'-methylenebis(cyclohexylamine), 1,4-bis(4-aminophenoxy)benzene, 4,4'-bis(4-aminophenoxy)biphenyl , 4,4'-diamino-2,2'-bis(trifluoromethyl) fluorene biphenyl, 4,4'-diamino-2,2'-dimethylbiphenyl, 2,6- Diamine-based, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminoacridine, in the compound represented by the above formula (D-I) The compound represented by the following formula (D-8), the compound represented by the following formula (D-9) in the compound represented by the above formula (D-II), and the compound represented by the above formula (D-III) At least one selected from the group consisting of the compound represented by the formula (D - 6) and the compound represented by the above formula (D-6) and the compound represented by the above formula (d-7) (hereinafter referred to as "other specific two

Η2Ν_^3~ΚΖ)-〇3Η6~~{Ζ/ν~^^~ιΗ2Ν_^3~ΚΖ)-〇3Η6~~{Ζ/ν~^^~ι

ch3 ch3 -22- .200948861 上述聚醯胺酸的合成中所使用的二胺,較佳係相對於 全部二胺,含有0.1〜50莫耳%上述式(A)表示的化合物, 更佳係含有0.5〜30莫耳%,特佳係含有1〜20莫耳%。通 過使上述式(A)表示的化合物的使用比例落在上述範圍 內,可以使所製得的液晶配向膜顯示優良的塗敷性,特別 是優良的印刷性’並且由其形成的液晶配向膜可更穩定地 表現高的預傾角’因此從這方面考慮爲較佳的。當上述式 (A)表示的化合物的使用比例相對於全部二胺落在〗〜5莫 0 耳%的範圍時,本發明的液晶配向劑可特別適用於TN型和 STN型液晶顯示元件。當上述式(A)表示的化合物的使用比 例相對於全部二胺落在10〜25莫耳%的範圍時,本發明的 液晶配向劑可特別適用於VA型液晶顯示元件。 上述聚醯胺酸的合成中所使用的二胺,較佳係相對於 全部二胺,含有5〜80莫耳%上述式(Β)表示的化合物,更 佳係含有1 0〜6 0莫耳%,特佳係含有2 0〜5 0莫耳%。 上述聚醯胺酸的合成中所使用的二胺,較佳係相對於 〇 全部二胺,含有10〜95莫耳%如上所述的其他特定二胺, 更佳係含有20〜90莫耳%,特佳係含有40〜80莫耳%。 <四羧酸二酐> 作爲上述聚醯胺酸的合成中所使用的四羧酸二酐,可 以列舉例如丁烷四羧酸二酐、1,2,3,4-環丁烷四羧酸二酐、 1,2-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基 -1,2,3,4-環丁烷四羧酸二酐、l,3-二氯_1,2,3,4-環丁烷四羧 酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、 1,2,3,4-環戊烷四羧酸二酐、l,2,4,5-環己烷四羧酸二酐、 -23- 200948861 3,3’,4,4’-二環己基四羧酸二酐、2,3,5-三羧基環戊基醋酸 二酐、3,5,6-三羧基-2-羧甲基降冰片烷-2:3,5:6-二酐、 2,3,4,5 -四氫呋喃四羧酸二酐、1,3,3&,4,5,91)-六氫-5-(四氫 • 2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、 1,3,3&,4,5,91)-六氫-5-甲基-5-(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,915-六氫-5-乙基-5-(四 氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、 1,3,3&,4,5,91)-六氫-7-甲基-5-(四氫-2,5-二氧代-3-呋喃基)-φ 萘[l,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,913-六氫-7-乙基-5-(四 氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、 1,3,3&,4,5,915-六氫-8-甲基-5-(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,913-六氫-8-乙基-5-(四 氫-2,5-二氧代-3-呋喃基)-萘[1,2-〇]-呋喃-1,3-二酮、 1,3,3&,4,5,91>-六氫-5,8-二甲基-5-(四氫-2,5-二氧代-3-呋喃 基)-萘[1,2-c]-呋喃-1,3-二酮、5-(2,5-二氧代四氫呋喃 基)_3_甲基_3_環己烯-1,2-二羧酸酐、雙環[2.2.2]-辛-7-烯 Ο -2,3,5,6-四羧酸二酐、下述式(T-Ι)和(T-II)各自表示的化 合物等脂肪族或脂環式四羧酸二酐,Ch3 ch3 -22-.200948861 The diamine used in the synthesis of the above polyamic acid preferably contains 0.1 to 50 mol% of the compound represented by the above formula (A), and more preferably contains all of the diamine. 0.5 to 30 mol%, and the special system contains 1 to 20 mol%. When the use ratio of the compound represented by the above formula (A) falls within the above range, the obtained liquid crystal alignment film can exhibit excellent coatability, particularly excellent printability, and a liquid crystal alignment film formed therefrom It is possible to exhibit a high pretilt angle more stably', and thus it is preferable from this point of view. When the use ratio of the compound represented by the above formula (A) is in the range of from 〜5 to 0% by mole based on the entire diamine, the liquid crystal alignment agent of the present invention can be particularly suitably used for the TN type and STN type liquid crystal display elements. When the use ratio of the compound represented by the above formula (A) falls within the range of 10 to 25 mol% with respect to the entire diamine, the liquid crystal alignment agent of the present invention can be particularly suitably used for a VA liquid crystal display element. The diamine used in the synthesis of the polyamic acid preferably contains 5 to 80 mol% of the compound represented by the above formula (Β) with respect to all the diamines, more preferably 10 to 60 mol. %, especially good contains 2 0~5 0 mol%. The diamine used in the synthesis of the above polyamic acid preferably contains 10 to 95 mol% of the other specific diamine as described above, more preferably 20 to 90 mol%, based on the total diamine. , especially good contains 40~80 mol%. <tetracarboxylic dianhydride> Examples of the tetracarboxylic dianhydride used in the synthesis of the polyamic acid include butane tetracarboxylic dianhydride and 1,2,3,4-cyclobutane IV. Carboxylic dianhydride, 1,2-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutane IV Carboxylic dianhydride, l,3-dichloro-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-ring Butane tetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, -23- 200948861 3,3' , 4,4'-dicyclohexyltetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 3,5,6-tricarboxy-2-carboxymethylnorbornane-2: 3,5:6-dianhydride, 2,3,4,5-tetrahydrofuran tetracarboxylic dianhydride, 1,3,3&,4,5,91)-hexahydro-5-(tetrahydro-2,5 -dioxo-3-furanyl)-naphthalene [l,2-c]-furan-1,3-dione, 1,3,3&,4,5,91)-hexahydro-5-methyl -5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]-furan-1,3-dione, 1,3,3&,4,5,915- Hexahydro-5-ethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]-furan-1,3-dione, 1 3,3&,4,5,91)-hexahydro-7-methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-φ naphthalene [l,2-c]- Furan-1,3-diketone, 1,3,3&,4,5,913-hexahydro-7-ethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene l,2-c]-furan-1,3-dione, 1,3,3&,4,5,915-hexahydro-8-methyl-5-(tetrahydro-2,5-dioxo-3 -furyl)-naphthalene [l,2-c]-furan-1,3-dione, 1,3,3&,4,5,913-hexahydro-8-ethyl-5-(tetrahydro-2, 5-dioxo-3-furanyl)-naphthalene [1,2-indolyl]-furan-1,3-dione, 1,3,3&,4,5,91>-hexahydro-5,8 -Dimethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [1,2-c]-furan-1,3-dione, 5-(2,5- Dioxotetrahydrofuranyl)_3_methyl_3_cyclohexene-1,2-dicarboxylic anhydride, bicyclo[2.2.2]-oct-7-eneΟ-2,3,5,6-tetracarboxylic acid An aliphatic or alicyclic tetracarboxylic dianhydride such as a dianhydride or a compound represented by the following formula (T-Ι) and (T-II),

Q R7 R7 PQ R7 R7 P

-24- .200948861 (式(Τ—I)和(Τ_ΙΙ)中,R4和R6各自表示具有芳香環 的2價有機基團,R5和R7各自表示氫原子或者烷基,存在 的多個R5和R7各自可以相同,也可以不同); 均苯四酸二酐、3,3’,4,4’-二苯酮四羧酸二酐、 3,3’,4,4’-二苯基楓四羧酸二酐、1,4,5,8-萘四羧酸二酐、 2,3,6,7-萘四羧酸二酐、3,3’,4,4’-二苯基醚四羧酸二酐、 3,3’,4,4’-二苯基甲烷四羧酸二酐、3,3’,4,4’-二甲基二苯基 矽烷四羧酸二酐、3,3’,4,4’-四苯基矽烷四羧酸二酐、 0 1,2,3,4-呋喃四羧酸二酐、4,4’-二(3,4-二羧基苯氧基)二苯 基硫醚二酐、4,4’-二(3,4-二羧基苯氧基)二苯基楓二酐、 4,4’-二(3,4-二羧基苯氧基)二苯基丙烷二酐、3,3’,4,4’-全 氟異伸丙基二鄰苯二甲酸二酐、3,3’,4,4’-聯苯四羧酸二 酐、二(鄰苯二甲酸)苯膦氧化物二酐、對亞苯基-二(三苯基 鄰苯二甲酸)二酐、間亞苯基-二(三苯基鄰苯二甲酸)二酐、 二(三苯基鄰苯二甲酸)-4,4’-二苯醚二酐、二(三苯基鄰苯二 甲酸)-4,4’-二苯基甲烷二酐、乙二醇-二(脫水偏苯三酸 〇 酯)、丙二醇-二(脫水偏苯三酸酯)、1,4-丁二醇-二(脫水偏 苯三酸酯)、1,6-己二醇-二(脫水偏苯三酸酯)、1,8-辛二醇-二(脫水偏苯三酸酯)、2,2-二(4-羥苯基)丙烷-二(脫水偏苯 三酸酯)、2,3,4,5-吡啶四羧酸二酐、2,6-二(3,4-二羧基苯基) 吡啶、下述式(T — 1)〜(T-4)各自表示的化合物等芳香族 四羧酸二酐。它們可以一種單獨或兩種以上組合使用。 -25- 200948861-24- .200948861 (In the formulas (Τ-I) and (Τ_ΙΙ), R4 and R6 each represent a divalent organic group having an aromatic ring, and R5 and R7 each represent a hydrogen atom or an alkyl group, and a plurality of R5 and R7 can be the same or different); pyromellitic dianhydride, 3,3',4,4'-benzophenonetetracarboxylic dianhydride, 3,3',4,4'-diphenyl maple Tetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 3,3',4,4'-diphenyl ether Tetracarboxylic dianhydride, 3,3',4,4'-diphenylmethanetetracarboxylic dianhydride, 3,3',4,4'-dimethyldiphenylnonanetetracarboxylic dianhydride, 3 , 3',4,4'-tetraphenylnonanetetracarboxylic dianhydride, 0 1,2,3,4-furan tetracarboxylic dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy Diphenyl sulfide dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenyl maple dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy Diphenylpropane dianhydride, 3,3',4,4'-perfluoroisopropenyldiphthalic dianhydride, 3,3',4,4'-biphenyltetracarboxylic dianhydride, Di(phthalic acid) phenylphosphine oxide dianhydride, p-phenylene-bis(triphenyl) Phthalic anhydride) dianhydride, m-phenylene-bis(triphenylphthalic acid) dianhydride, bis(triphenylphthalic acid)-4,4'-diphenyl ether dianhydride, two (three) Phenylphthalic acid)-4,4'-diphenylmethane dianhydride, ethylene glycol-di(decyl trimellitate), propylene glycol-di(hydrogen trimellitate), 1,4 - Butanediol-di(hydrogen trimellitate), 1,6-hexanediol-di(hydroper trimellitate), 1,8-octanediol-di(anhydrotrimellitic acid ester) , 2,2-bis(4-hydroxyphenyl)propane-di(hydroper trimellitate), 2,3,4,5-pyridinetetracarboxylic dianhydride, 2,6-di(3,4- An aromatic tetracarboxylic dianhydride such as a compound represented by the following formula (T-1) to (T-4) of dicarboxyphenyl)pyridine. They may be used alone or in combination of two or more. -25- 200948861

作爲上述聚醯胺酸的合成中所使用的四羧酸二酐,上 述當中,從使所形成的液晶配向膜表現良好的液晶配向性 的角度出發,較佳係含有由丁烷四羧酸二酐、1,2,3,4-環丁 烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、 1,2,3,4-環戊烷四羧酸二酐、2,3,5-三羧基環戊基醋酸二 酐、3,5,6-三羧基-2-羧甲基降冰片烷- 2:3,5:6-二酐、5-(2,5-二氧代四氫呋喃基)-3 -甲基-3-環己烯-1,2-二羧酸酐、 l,3,3a,4,5,9b-六氫-5-(四氫-2,5-二氧代-3-呋喃基)-萘 [1,2-c] -呋喃-1,3 -二酮、1,3,3a,4,5,9b -六氫-8-甲基- 5- (四氫 -2,5-二氧代-3-呋喃基)-萘[1,2-〇]-呋喃-1,3-二酮、 1,3,3a,4,5,9b-六氫-5,8-二甲基- 5-(四氫-2,5-二氧代-3-呋喃 -26- 200948861 基萘 n,2-c]_呋喃.υ·二酮、雙環[2.2 2]•辛 _7|2 3’5 6_ 四殘酸二if、均苯四酸二肝、3,3,,4,4,<苯酮四竣酸二酐、 ^,,^,-二苯基楓四隨二^丄萘四竣酸二^上 述式(T — I)表示的化合物中的下述武(τ_ 5)〜(τ_ 7)各自 表示的化合物以及上述式(τ— Π)表希的化合物中的下述式 (τ~ 8)表示的化合物構成的群組中選出的至少一種(以下 稱爲“特定四羧酸二酐”)的四羧酸二酐。In the above, the tetracarboxylic dianhydride used in the synthesis of the polyamic acid is preferably a butane tetracarboxylic acid from the viewpoint of exhibiting a liquid crystal alignment property in which the formed liquid crystal alignment film is excellent. Anhydride, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3, 4-cyclopentane tetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 3,5,6-tricarboxy-2-carboxymethylnorbornane-2:3,5: 6-dianhydride, 5-(2,5-dioxotetrahydrofuranyl)-3-methyl-3-cyclohexene-1,2-dicarboxylic anhydride, l,3,3a,4,5,9b- Hexahydro-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene[1,2-c]-furan-1,3-dione, 1,3,3a,4,5 , 9b-hexahydro-8-methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene[1,2-indolyl]-furan-1,3-dione, 1 ,3,3a,4,5,9b-hexahydro-5,8-dimethyl-5-(tetrahydro-2,5-dioxo-3-furan-26- 200948861 naphthalene n,2-c ]_furan.υ·dione, bicyclo[2.2 2]•xin_7|2 3′5 6_ tetraresidic acid di, pyromellitic acid dihepatic, 3,3,,4,4,<benzophenone Tetraphthalic acid dianhydride, ^,, ^,-diphenyl maple four with two Naphthyltetradecanoic acid is the compound represented by the above formula (T - I), and the compound represented by the following formula (τ_5) to (τ_7) and the compound of the above formula (τ-Π) A tetracarboxylic dianhydride of at least one selected from the group consisting of compounds represented by the formula (τ-8) (hereinafter referred to as "specific tetracarboxylic dianhydride").

ΟΟ

特佳的特定四羧酸二酐爲由1,2,3,4-環丁烷四羧酸二 酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、2,3,5-三羧基 環戊基醋酸二酐、3,5,6-三羧基-2-羧甲基降冰片院·2:3,5:6-二酐、1,3,38,4,5,915-六氫-5-(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫 _8_ 甲基 _5-(四 氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃- I,3-二酮、均苯四 -27- 200948861 酸二酐以及上述式(Τ — 5)〜(Τ - 8)各自表示的化合物構成 的群組中選出的至少一種。 上述聚醯胺酸的合成中所使用的四羧酸二酐,較佳係 相對於全部四羧酸二酐’含有80莫耳%以上如上所述的特 定四羧酸二酐’更佳係含有90莫耳%以上,特佳係含有95 莫耳%以上。 &lt;聚醯胺酸的合成&gt; 本發明中所用的聚醯胺酸’可以通過使如上所述的四 Q 羧酸二酐與二胺反應而合成。 供給聚醯胺酸的反應的四羧酸二酐的使用比例,較佳 係相對於二胺中所含的1當量胺基,使四羧酸二酐的酸酐 基爲〇_5〜2當量的比例,更佳係使其爲〇.7〜1.2當量的比 例。由於若四羧酸二酐的酸酐基爲0.5〜2當量的比例,則 聚合度容易提高,因而從這一點上爲較佳的。若爲0.7〜1.2 當量的比例,則聚合度特別容易提高,因而從這一點上是 更佳係的。 〇 上述聚醯胺酸還可以是進行了分子量調節的末端修飾 型聚醯胺酸。通過使用該末端修飾型的聚酿胺酸,可以在 不損害本發明效果的前提下進一步改善液晶配向劑的塗敷 性能等。這種末端修飾型聚醯胺酸可以通過在聚醯胺酸的 合成時,向反應體系中加入單酐、單胺化合物、單異氰酸 酯化合物等合適的分子量調節劑而合成。 作爲上述單酐,可以列舉例如馬來酸酐、鄰苯二甲酸 酐、衣康酸酐、正癸基琥珀酸酐、正十二烷基琥珀酸酐、 正十四烷基琥珀酸酐或正十六烷基琥珀酸酐等。作爲單胺 -28- .200948861 化合物,可以列舉例如苯胺、環己胺、正丁胺、正戊胺、 正己胺、正庚胺、正辛胺、正壬胺、正癸胺、正十一烷胺、 正十二烷胺、正十三烷胺、正十四烷胺、正十五烷胺、正 十六烷胺、正十七烷胺、正十八烷胺或正二十烷胺等。作 爲單異氰酸酯化合物,可以列舉例如異氰酸苯酯或異氰酸 萘基酯等。 這些分子量調節劑的使用比例,相對於100重量份聚 醯胺酸合成時所使用的四羧酸二酐和二胺的合計量,較佳 Ο 係爲20重量份以下,更佳係爲10重量份以下。 聚醯胺酸的合成反應,在有機溶劑中,較佳係於-20〜 150 °C、更佳係於0〜100 °C的溫度條件下進行,反應時間 較佳爲0.5〜1 2 0小時,更佳係爲2〜1 0小時。這裏,作爲 有機溶劑,只要是能夠溶解合成的聚醯胺酸的溶劑,則對 其沒有特別的限制,可以例示例如N-甲基-2-耻咯烷酮、 N,N-二甲基乙醯胺、N,N-二甲基甲醯胺、二甲基亞楓、r-丁內酯、四甲基脲、六甲基磷醯三胺等非質子類極性溶劑; G 間甲基酚、二甲苯酚、苯酚、鹵代苯酚等酚類溶劑》另外, 有機溶劑的用量(a),較佳係爲使四羧酸二酐和二胺的總量 (b)相對於反應溶液的總量(a + b)爲0.1〜30重量%的量。另 外,當有機溶劑與下述不良溶劑倂用時,上述有機溶劑的 用量是指有機溶劑與不良溶劑的合計量的含義。 上述有機溶劑中,在不使生成的聚醯胺酸析出的範圍 內,還可以併用聚醯胺酸的不良溶劑醇類、酮類、酯類、 醚類、鹵代烴類和烴類等。作爲這種不良溶劑的具體例子, 可以列舉例如甲醇、乙醇、異丙醇、環己醇、乙二醇、丙 -29- 200948861 二醇、1,4-丁二醇、三甘醇、乙二醇單甲醚、乳酸乙酯、 乳酸丁酯、丙酮、甲基乙基酮、甲基異丁基酮、環己酮、 醋酸甲酯、醋酸乙酯、醋酸丁酯、甲氧基丙酸甲酯、乙氧 基丙酸乙酯、草酸二乙酯、丙二酸二乙酯、乙醚、乙二醇 甲醚、乙二醇乙醚、乙二醇正丙醚、乙二醇異丙醚、乙二 醇正丁醚、乙二醇二甲基醚、乙二醇乙醚乙酸酯、二甘醇 二甲醚、二甘醇二乙醚、二甘醇單甲醚、二甘醇單乙醚、 二甘醇單甲醚乙酸酯、二甘醇單乙醚乙酸酯、四氫呋喃、 φ 二氯甲烷、1,2-二氯乙烷、1,4-二氯丁烷、三氯乙烷、氯苯、 鄰二氯苯、己烷、庚烷、辛烷、苯、甲苯、二甲苯等。 當將有機溶劑與不良溶劑倂用時,不良溶劑的使用比 例,相對於有機溶劑與不良溶劑的合計量,較佳係爲50重 量%以下,更佳係爲20重量%以下,特別較佳爲1 0重量% 以下。 如上所述,得到溶解了聚醯胺酸的反應溶液。_反應 溶液可以直接供給液晶配向劑的配製,也可以將反應溶液 〇 中所含的聚醯胺酸分離出來後供給液晶配向劑的配製,或 者也可以將分離出的聚醯胺酸精製後再供給液晶配向劑的 配製。聚醯胺酸的分離,可以通過將上述反應溶液投入到 大量的不良溶劑中,得到析出物,再減壓乾燥該析出物的 方法’或者將反應溶液用蒸發器減壓餾出的方法而進行。 另外’通過進行一次或者幾次使該聚醯胺酸再次溶解於有 機溶劑中’然後用不良溶劑使其析出的方法,或用蒸發器 減壓餾出的步驟,可以精製聚醯胺酸。 &lt;醯亞胺化聚合物&gt; -30- 200948861 本發明中使用的醯亞胺化聚合物,可以通過將如上所 述的聚醯胺酸脫水閉環而合成。聚醯胺酸的脫水閉環,可 以(I)通過加熱聚醯胺酸的方法,或者(II)通過將聚醯胺酸 溶解於有機溶劑中,向該溶液中加入脫水劑和脫水閉環催 化劑並根據需要加熱的方法而進行。 上述(I)的加熱聚醯胺酸的方法中的反應溫度,較佳係 爲50〜200 °C,更佳係爲60〜170 °c。當反應溫度不足50 °C時,則脫水閉環反應不能進行充分,若反應溫度超過200 〇 °c,則會出現所得醯亞胺化聚合物的分子量下降的情況。 反應時間較佳爲1〜120小時,更佳係爲2〜30小時。 在上述(II)的在聚醯胺酸溶液中添加脫水劑和脫水閉 環催化劑的方法中,作爲脫水劑,可以使用例如醋酸酐、 丙酸酐、三氟乙酸酐等酸酐。脫水劑的用量,較佳係相對 於聚醯胺酸的1莫耳重複單元爲0.01〜20莫耳。另外,作 爲脫水閉環催化劑,可以使用例如吡啶、三甲吡啶、二甲 吡啶、三乙胺等叔胺》但是並不侷限於這些。脫水閉環催 Ο 化劑的用量,相對於1莫耳所用脫水劑,較佳係爲0.01〜 1 0莫耳。作爲脫水閉環反應中使用的有機溶劑,可以列舉 作爲聚醯胺酸合成中所用溶劑而例示的有機溶劑。另外, 脫水閉環反應的反應溫度,較佳係爲0〜180 °c,更佳係爲 10〜150 °C。反應時間較佳爲0.5〜30小時,更佳係爲2〜 1 0小時。 上述方法(I)中製得的醯亞胺化聚合物,可以將其直接 供給液晶配向劑的配製,或者也可以將製得的醯亞胺化聚 合物精製後再供給液晶配向劑的配製。另外,在上述方法 -31- 200948861 (II)中,得到含醯亞胺化聚合物的反應溶液。該反 可以將其直接供給液晶配向劑的配製,也可以從 中除去脫水劑和脫水閉環催化劑之後供給液晶配 製,還可以將醯亞胺化聚合物分離出來後供給液 的配製,或者也可以將分離的醯亞胺化聚合物精 給液晶配向劑的配製。從反應溶液中除去脫水劑 環催化劑,可以採用例如溶劑置換等方法。醯亞 物的分離、精製,可以採取與以上作爲聚醯胺酸 0 精製方法所描述的同樣的操作而進行。 本發明中使用的醯亞胺化聚合物,可以是其 胺酸所具有的醯胺酸結構全部脫水閉環的完全 物,或者也可以是僅部分醯胺酸結構脫水閉環、 構與醯亞胺環並存的醯亞胺化物。 醯亞胺化聚合物的醯亞胺化率,較佳係爲1 更佳係爲10〜98%,進一步較佳爲40〜90%。這 “醯亞胺化率”,是指相對於聚合物中的醯胺酸 © 與醯亞胺環數量的合計數量,醯亞胺環結構的數 百分率表示的値。此時,醯亞胺環的一部分也可 亞胺環。醯亞胺化率可以通過調節上述脫水閉環 應條件而隨意控制。 &lt;聚醯胺酸和醯亞胺化聚合物的溶液黏度&gt; 本發明中所用的聚醯胺酸和醯亞胺化聚合物 配成濃度爲10重量%的溶液時,較佳係具有20〜 s的溶液黏度’更佳係具有30〜500 mPa.s的溶密 上述聚合物的溶液黏度(mPa_s),是對採用該 應溶液, 反應溶液 向劑的配 晶配向劑 製後再供 和脫水閉 胺化聚合 的分離、 先質聚醯 醯亞胺化 醯胺酸結 〜100%, 裏,所謂 結構數量 量比例用 以是異醯 反應的反 ,當分別 -8 0 0 m P a * e黏度。 聚合物的 -32- 200948861 良溶劑(例如N-甲基-2-吡咯烷酮、丁內酯等)配成的ι〇 重量%濃度的聚合物溶液,用E型旋轉黏度計在25 °C下測 定的値。 &lt;其他成分&gt; 本發明液晶配向劑,包括由如上所述的特定聚醯胺酸 和醯亞胺化聚合物構成的群組中選出的至少一種聚合物, 而在不損害本發明效果和優點的前提下,還可以任選地含 有其他成分。作爲這種其他成分,可以列舉例如分子內具 φ 有至少一個環氧基的化合物(以下稱爲“環氧基化合 物”)、官能性矽烷化合物等》 作爲上述環氧基化合物,較佳係的可以列舉例如乙二 醇二縮水甘油醚、聚乙二醇二縮水甘油醚、丙二醇二縮水 甘油醚、三丙二醇二縮水甘油醚、聚丙二醇二縮水甘油醚、 新戊二醇二縮水甘油醚、1,6-己二醇二縮水甘油醚、甘油 二縮水甘油魅、2,2-二溴新戊二醇二縮水甘油醚、 \:^”’,:^’-四縮水甘油基-間苯二甲胺、1,3-二(1^,;^-二縮水 ❹ 甘油基胺基甲基)環己烷、N,N,N’,N’·四縮水甘油基·4,4’-二胺基二苯基甲烷、Ν,Ν-二縮水甘油基-苄胺、Ν,Ν-二縮水 甘油基-胺基甲基環己烷等。這些環氧基化合物的混合比 例,相對於1 00重量份聚合物,較佳係爲40重量份以下, 更佳係爲0.1〜30重量份。 作爲上述官能性矽烷化合物,可以列舉例如3 -胺基丙 基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、2-胺基丙基 三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、Ν-(2·胺基乙 基)-3-胺基丙基三甲氧基矽烷、Ν-(2-胺基乙基)-3-胺基丙基 -33- 200948861 甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙 基三乙氧基矽烷、N-乙氧羰基-3-胺基丙基三甲氧基矽烷、 N-乙氧羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽烷基 丙基三伸乙基三胺、N-三甲氧基矽烷基丙基三伸乙基三 胺、10-三甲氧基矽烷-1,4,7-三氮雜癸烷、10-三乙氧基矽 烷基-1,4,7-三氮雜癸烷、9-三甲氧基矽烷基-3,6·二氮雜壬 基乙酸酯、9-三乙氧基矽烷基-3,6-二氮雜壬基乙酸酯、9-三甲氧基矽烷基-3,6-二氮雜壬酸甲酯、9-三乙氧基矽烷基 ❹ -3,6·二氮雜壬酸甲酯、N-苄基-3·胺基丙基三甲氧基矽烷、 N-苄基-3-胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三甲 氧基矽烷、N-苯基-3-胺基丙基三乙氧基矽烷、環氧丙氧基 甲基三甲氧基矽烷、環氧丙氧基甲基三乙氧基矽烷、2-環 氧丙氧基乙基三甲氧基矽烷、2-環氧丙氧基乙基三乙氧基 矽烷、3-環氧丙氧基丙基三甲氧基矽烷、3-環氧丙氧基丙 基三乙氧基矽烷等。 這些官能性矽烷化合物的混合比例,相對於1 00重量 ❹ 份聚合物,較佳係爲2重量份以下,更佳係爲0.2重量份 以下。 &lt;液晶配向劑&gt; 本發明的液晶配向劑是將如上所述的聚合物以及任選 使用的其他成分較佳係溶解含於有機溶劑中而構成的。 作爲本發明液晶配向劑中可以使用的有機溶劑,可以 列舉作爲聚醯胺酸的合成反應中所用的溶劑而例示的溶 劑。還可以適當地選擇倂用作爲聚醯胺酸的合成反應時可 以倂用的不良溶劑而例示的溶劑。 -34- 200948861 作爲本發明液晶配向劑中可以使用的特佳的有機溶 劑,可以列舉例如N-甲基-2-吡咯烷酮、r-丁內酯、r-丁 內醯胺、Ν,Ν-二甲基甲醯胺、N,N-二甲基乙醯胺、4-羥基 -4-甲基-2-戊酮、乙二醇單甲醚、乳酸丁酯、乙酸丁酯、甲 氧基丙酸甲酯、乙氧基丙酸乙酯、乙二醇甲醚、乙二醇乙 醚、乙二醇正丙醚、乙二醇異丙醚、乙二醇正丁醚(丁基溶 纖劑)、乙二醇二甲基醚、乙二醇乙醚乙酸酯、二甘醇二甲 醚、二甘醇二乙醚、二甘醇單甲醚、二甘醇單乙醚、二甘 0 醇單甲醚乙酸酯、二甘醇單乙醚乙酸酯、丙酸異戊酯、異 丁酸異戊酯、異戊醚、碳酸乙二酯、碳酸丙二酯等。它們 可以單獨使用,或者也可以兩種以上混合使用。 特佳的溶劑組成,是使上述溶劑組合所得的組成,是 聚合物不會從配向劑中析出,且使配向劑的表面張力落在 25〜40mN/m範圍的組成。 本發明液晶配向劑的固體含量濃度(液晶配向劑中的 溶劑以外的成分的合計重量占液晶配向劑總重量的比例) Q 考慮黏性、揮發性等而進行選擇。較佳爲1〜10重量%。 也就是說,本發明的液晶配向劑,通過將其塗敷於基板表 面,然後除去溶劑而形成作爲液晶配向膜的塗膜,當固體 含量濃度不足1重量%時,將會導致該塗膜的厚度過4、而 難以獲得良好的液晶配向膜,而當固體含量濃度超過10重 量%時,將導致塗膜的厚度過厚而同樣難以獲得良好的液 晶配向膜,並且,會出現液晶配向劑黏性增大導致塗敷性 能變差的情況,因此是不佳的。 特佳的固體含量濃度範圍,根據將液晶配向劑塗敷於 -35- 200948861 基板時所採用的方法而不同。例如’當採用旋塗法時,特 佳係1 .5〜4.5重量°/。的範圍。當採用印刷法時’特佳係使 固體含量濃度爲3〜9重量%的範圍’這樣’可以使溶液黏 度落在12〜50 rnPa’s的範圍。當採用噴墨法時’特佳係使 固體含量濃度爲1〜5重量%的範圍’這樣’可以使溶液黏 度落在3〜15 mPa’s的範圍。 配製本發明液晶配向劑時的溫度’較佳係爲〇°C〜200 °C,更佳係爲20°C〜60°C。 0 〈液晶顯示元件&gt; 本發明的液晶顯示元件具有由如上所述的本發明液晶 配向劑形成的液晶配向膜。 本發明的液晶顯示元件可以通過例如以下(1)〜(3 )的 方法製造。 (1)採用例如輥塗法、旋塗法、印刷法、噴墨法等適當 的塗敷方法,將本發明的液晶配向劑塗敷於設有形成圖案 狀透明導電膜的基板的透明導電膜一側,然後通過加熱塗 © 敷面形成塗膜。 作爲上述基板,可以使用例如浮法玻璃、鈉鈣玻璃等 玻璃、聚對苯二甲酸乙二醇酯、聚對苯二甲酸丁二醇酯、 聚醚楓、聚碳酸酯、聚(脂環式烯烴)等塑膠製透明基板等。 作爲上述透明導電膜,可以使用Sn02製的NESA膜、 ln203 — Sn02製的ITO膜等。這些形成圖案狀透明導電膜的 形成,可採用在形成無形成圖案的透明導電膜後通過光刻 蝕法形成圖案的方法、在透明導電膜形成時採用具有所需 形成圖案的遮罩直接形成圖案狀透明導電膜的方法等。 -36- 200948861 在液晶配向劑的塗敷時,爲了進一步改善基板和透明 導電膜與塗膜的黏附性,還可以在基板和透明導電膜上, 預先塗敷官能性矽烷化合物、鈦酸酯等。 塗敷液晶配向劑後的加熱溫度,較佳係爲80〜3 0 0°C, 更佳係爲120〜250 °C。加熱時間較佳爲5〜200分鐘,更 佳係爲1 0〜1 00分鐘。本發明的液晶配向劑通過如上所述 塗敷後除去有機溶劑而形成作爲液晶配向膜的塗膜,而當 本發明的液晶配向劑中所含的聚合物爲聚醯胺酸或者同時 φ 存在醯亞胺環結構和醯胺酸結構的醯亞胺化聚合物時,還 可以在形成塗膜後通過進一步加熱使其進行脫水閉環反 應,以形成進一步醴亞胺化的塗膜。 形成的塗膜的厚度,作爲除去溶劑後的厚度,較佳係 爲 0.001 〜l;am,更佳係爲 0.005 〜0.5/zm。 另外,當應用本發明液晶配向劑的液晶顯示元件爲VA 型液晶顯示元件時,還可以例如專利文獻 14(日本特開 2002-327058號公報)中所述,在基板上形成突起狀構造物 〇 後塗敷液晶配向劑,以達到改善視角性能的目的。 (2)如上形成的塗膜,可以直接作爲VA型液晶顯示元 件的液晶配向膜使用,也可以根據需要進行如下的打磨處 理。 當將上述塗膜作爲TN型或STN型液晶顯示元件的液 晶配向膜使用時,採用纏有例如尼龍、人造纖維、棉花等 纖維製的布的輥對如上所述形成的塗膜面進行以一定方向 摩擦的打磨處理。這樣,賦予塗膜以液晶分子的配向能, 形成液晶配向膜。通過對如上形成的液晶配向膜,進行例 -37- 200948861 如專利文獻15(日本特開平U22366號公報)或專利文獻 16(日本特開平6-2 81937號公報)中所示的、部分照射紫外 線以改變預傾角的處理,或者進行專利文獻17(日本特開平 5-107544號公報)中所示的、在進行了打磨處理的液晶配向 膜表面上部分地形成抗蝕膜後,以與先前打磨處理不同的 方向進行打磨處理後除去抗蝕膜,以使液晶配向膜的液晶 配向能發生改變的處理,能夠改善液晶顯示元件的視場性 會b - 〇 (3)製造兩塊如上形成了液晶配向膜的基板,將兩塊基 板通過間隙(晶胞間隙)相對放置。將兩塊基板周邊部位用 密封劑貼合,向由基板表面和密封劑圍成的晶胞間隙內注 充液晶,封閉注入孔,構成液晶胞。然後,在液晶胞的各 外表面,即兩者的透明基板一側,分別設置偏光板,製得 液晶顯示元件。這裏,作爲密封劑,可以使用例如含作爲 硬化劑和分隔物的氧化鋁球的環氧樹脂等。 作爲液晶,可以列舉向列型液晶和碟狀型液晶,其中 Ο 較佳係向列型液晶,可以使用例如希夫氏城類液晶、氧化 偶氮基類液晶、聯苯類液晶、苯基環己烷類液晶、酯類液 晶、三聯苯類液晶、聯苯基環己烷類液晶、嘧啶類液晶、 二氧六環類液晶、雙環辛烷類液晶、立方烷類液晶等。此 外’這些液晶中還可以添加例如氯化膽甾醇、膽甾醇壬酸 酯、膽甾醇碳酸酯等膽甾型液晶、以商品名“ C-1 5 ” 、 “CB-15”(默克公司製)銷售的對掌劑等而進行使用。 作爲液晶胞外表面上貼合的偏光板,可以列舉將聚乙 烯醇延伸配向同時吸收碘所得的稱作爲“ Η膜”的偏光膜 -38- « 200948861 夾在醋酸纖維保護膜中而製成的偏光板,或者Η膜自身製 成的偏光板。 【實施例】 以下,通過實施例對本發明進行更具體地說明,但是 本發明並不侷限於這些實施例。 以下的合成例中聚合物的溶液黏度、醯亞胺化聚合物 的醯亞胺化率,分別採用以下的方法評價。 [聚合物的溶液黏度] 〇 聚合物的溶液黏度(mPa· S)是對各聚合物溶液採用Ε 型旋轉黏度計在25°C下測定的。 [醯亞胺化聚合物的醯亞胺率] 將醯亞胺化聚合物在室溫下減壓乾燥後,使其溶於氘 代二甲亞颯中,以四甲基矽烷爲基準物,由室溫下測定的 W-NMR,通過下述公式(i)求出。 醯亞胺化率(%)= (1 - A^A^cOxlOO (i) A1: 10 ppm附近出現的來自於NH基質子的波峰面積 Ο A2:來自於其他質子的波峰面積 α:相對於醯亞胺化聚合物先質(聚醯胺酸)中的1個nh 基質子,其他質子的個數比例。 合成例1(醯亞胺化聚合物Α1的合成) 將作爲四羧酸二酐的3,5,6-三羧基-2-羧甲基降冰片院 -2:3,5:6-二酐1258(0.50莫耳),作爲二胺的上述式(^—1) 表示的化合物147g(0.24莫耳)、對苯二胺26g(0.24莫耳) 和3,5 -—胺基苯甲酸膽留院基醋10.4g(〇.〇2莫耳)溶於 1230gN -甲基-2 -吡咯烷酮中,在60°C下反應6小時。取少 -39- 200948861 量所得聚醯胺酸溶液’加入N-甲基-2-耻咯烷酮’配成聚醯 胺酸濃度爲1〇重量%的溶液’測定的溶液黏度爲50 mP a· s。 然後,向所得聚醯胺酸溶液中追加190 0g r-丁內酯, 再加入80g吡啶和l〇〇g醋酸酐’在1 l〇°C下進行4小時脫 水閉環反應。脫水閉環反應後,通過將體系內的溶劑用新 的 r-丁內酯進行溶劑置換(在此操作中將脫水閉環反應中 使用的吡啶和醋酸酐除去至體系外),得到約1 900g含有15 重量%醯亞胺化率約爲80%的醯亞胺化聚合物A1的溶液。 ❹ 取少量該溶液,用7&quot;-丁內酯稀釋,配成醯亞胺化聚合物濃 度爲10重量%的溶液,測定的溶液黏度爲40 mP a.s。 合成例2〜8、比較合成例1〜6(醯亞胺化聚合物A2〜 A8和比較用醯亞胺化聚合物R1〜R6的合成) 除了分別使用表1中所列種類和量的二胺和四羧酸二 酐以外,與上述合成例1同樣地操作,分別製得含有醯亞 胺化聚合物A2〜A8和比較用醯亞胺化聚合物R1〜R6的溶 液。各醯亞胺化聚合物的醯亞胺化率列於表1。 © 另外,在表1中,“化合物A”和“化合物B”分別 是指上述式(A)表示的化合物和上述式(B)表示的化合物, 各化合物的簡稱分別指下述含義,各化合物的“量”的單 位爲莫耳。另外,在比較合成例1〜6中,其他二胺分別每 例使用兩種。 &lt;二胺&gt; [上述式(A)表示的化合物] bl: 3,5-二胺基苯甲酸膽甾烷基酯 b2: 1-膽甾烷氧基-2,4-二胺基苯 -40- 200948861 [上述式(B)表示的化合物] b3 :上述式(B— 1)表示的化合物 b4:上述式(B - 2)表示的化合物 b5:上述式(B— 3)表示的化合物 b6:上述式(B— 7)表示的化合物 b7:上述式(B— 9)表示的化合物 b8:上述式(B-11)表示的化合物 b9:上述式(B— 17)表示的化合物 ❹ blO :上述式(B — 21)表示的化合物 [其他二胺] bll: 1-十八烷氧基-2,4-二胺基苯 bl2 :對苯二胺 &lt;四羧酸二酐&gt; al : 3,5,6-三羧基-2-羧甲基降冰片烷- 2:3,5:6-二酐 a2: 2,3,5-三羧基環戊基醋酸二酐Particularly preferred specific tetracarboxylic dianhydride is 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic acid Diacetate, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 3,5,6-tricarboxy-2-carboxymethylnorbornazole, 2:3,5:6-dianhydride, 1,3 ,38,4,5,915-hexahydro-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]-furan-1,3-dione, 1, 3,3a,4,5,9b-hexahydro_8_methyl_5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene[l,2-c]-furan-I, 3-diketone, pyromelli-4-27-200948861 Acid dianhydride and at least one selected from the group consisting of compounds represented by the above formulas (Τ-5)~(Τ-8). The tetracarboxylic dianhydride used in the synthesis of the polyamic acid is preferably contained in an amount of 80 mol% or more of the specific tetracarboxylic dianhydride as described above with respect to all tetracarboxylic dianhydrides. 90% or more of Mo, more than 95% Mo. &lt;Synthesis of Polyproline&gt; The polyglycolic acid ' used in the present invention can be synthesized by reacting the tetracarboxylic dianhydride as described above with a diamine. The ratio of the tetracarboxylic dianhydride to be used for the reaction of the poly-proline is preferably from 1 to 2 equivalents based on 1 equivalent of the amine group contained in the diamine. The ratio is preferably such that it is a ratio of 〇.7 to 1.2 equivalents. When the acid anhydride group of the tetracarboxylic dianhydride is in a ratio of 0.5 to 2 equivalents, the degree of polymerization is likely to be improved, which is preferable from this point. If the ratio is from 0.7 to 1.2 equivalents, the degree of polymerization is particularly easy to increase, and thus it is more preferable from this point. 〇 The above polylysine may also be a terminally modified polylysine having a molecular weight adjustment. By using the terminal-modified polyacrylic acid, the coating performance and the like of the liquid crystal alignment agent can be further improved without impairing the effects of the present invention. Such a terminal-modified polyglycolic acid can be synthesized by adding a suitable molecular weight modifier such as a monoanhydride, a monoamine compound or a monoisocyanate compound to the reaction system during the synthesis of polyamic acid. As the above monoanhydride, for example, maleic anhydride, phthalic anhydride, itaconic anhydride, n-decyl succinic anhydride, n-dodecyl succinic anhydride, n-tetradecyl succinic anhydride or n-hexadecyl amber may be mentioned. Anhydride, etc. As the monoamine-28-.200948861 compound, for example, aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, n-decylamine, n-decylamine, n-undecane may be mentioned. Amine, n-dodecylamine, n-tridecylamine, n-tetradecylamine, n-pentadecylamine, n-hexadecaneamine, n-heptadecaneamine, n-octadecylamine or n-icosylamine . The monoisocyanate compound may, for example, be phenyl isocyanate or naphthyl isocyanate. The ratio of use of the molecular weight modifier is preferably 20 parts by weight or less, more preferably 10 parts by weight based on the total amount of the tetracarboxylic dianhydride and the diamine used in the synthesis of the polyglycolic acid. The following. The synthesis reaction of polylysine is carried out in an organic solvent, preferably at -20 to 150 ° C, more preferably at a temperature of 0 to 100 ° C, and the reaction time is preferably 0.5 to 120 hours. The better system is 2 to 1 hour. Here, the organic solvent is not particularly limited as long as it is a solvent capable of dissolving the synthesized polyaminic acid, and examples thereof include N-methyl-2-foslacone and N,N-dimethyl B. Aprotic polar solvents such as decylamine, N,N-dimethylformamide, dimethyl sulfoxide, r-butyrolactone, tetramethylurea, hexamethylphosphonium triamine; G-m-methylphenol a phenolic solvent such as xylenol, phenol or a halogenated phenol. In addition, the amount (a) of the organic solvent is preferably such that the total amount of the tetracarboxylic dianhydride and the diamine (b) is relative to the total amount of the reaction solution. The amount (a + b) is an amount of 0.1 to 30% by weight. Further, when the organic solvent is used in combination with the following poor solvent, the amount of the above organic solvent means the total amount of the organic solvent and the poor solvent. In the above organic solvent, a poor solvent alcohol of polyacrylic acid, a ketone, an ester, an ether, a halogenated hydrocarbon, a hydrocarbon, or the like may be used in combination in a range in which the produced polyamine acid is not precipitated. Specific examples of such a poor solvent include methanol, ethanol, isopropanol, cyclohexanol, ethylene glycol, C--29-200948861 diol, 1,4-butanediol, triethylene glycol, and ethylene. Alcohol monomethyl ether, ethyl lactate, butyl lactate, acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, methyl acetate, ethyl acetate, butyl acetate, methoxy propionate Ester, ethyl ethoxypropionate, diethyl oxalate, diethyl malonate, diethyl ether, ethylene glycol methyl ether, ethylene glycol ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene Alcohol n-butyl ether, ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diglyme, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol Methyl ether acetate, diethylene glycol monoethyl ether acetate, tetrahydrofuran, φ dichloromethane, 1,2-dichloroethane, 1,4-dichlorobutane, trichloroethane, chlorobenzene, o-di Chlorobenzene, hexane, heptane, octane, benzene, toluene, xylene, and the like. When the organic solvent and the poor solvent are used, the ratio of the use of the poor solvent is preferably 50% by weight or less, more preferably 20% by weight or less, and particularly preferably 20% by weight or less based on the total amount of the organic solvent and the poor solvent. 10% by weight or less. As described above, a reaction solution in which polylysine was dissolved was obtained. The reaction solution may be directly supplied to the preparation of the liquid crystal alignment agent, or the polyphthalic acid contained in the reaction solution may be separated and supplied to the liquid crystal alignment agent, or the separated polyamic acid may be refined. The preparation of the liquid crystal alignment agent is supplied. The separation of the polyamic acid can be carried out by introducing the reaction solution into a large amount of a poor solvent to obtain a precipitate, and then drying the precipitate under reduced pressure or by subjecting the reaction solution to distillation under reduced pressure using an evaporator. . Further, the poly-proline can be purified by a method of re-dissolving the polyamine in an organic solvent once or several times and then precipitating it with a poor solvent or by distilling off under reduced pressure with an evaporator. &lt;醯i-Iminylated Polymer&gt; -30- 200948861 The ruthenium iodide polymer used in the present invention can be synthesized by dehydrating and ring-closing the polylysine as described above. a dehydration ring closure of polylysine, which may be (I) by heating poly-proline, or (II) by dissolving poly-proline in an organic solvent, adding a dehydrating agent and a dehydration ring-closing catalyst to the solution according to It needs to be carried out by heating. The reaction temperature in the method for heating poly-proline in the above (I) is preferably 50 to 200 ° C, more preferably 60 to 170 ° C. When the reaction temperature is less than 50 °C, the dehydration ring-closure reaction cannot be sufficiently carried out. If the reaction temperature exceeds 200 °C, the molecular weight of the obtained quinone imidized polymer may decrease. The reaction time is preferably from 1 to 120 hours, more preferably from 2 to 30 hours. In the method of adding a dehydrating agent and a dehydrated closed-loop catalyst to the polyamic acid solution of the above (II), an acid anhydride such as acetic anhydride, propionic anhydride or trifluoroacetic anhydride can be used as the dehydrating agent. The amount of the dehydrating agent is preferably 0.01 to 20 moles per 1 mole of the repeating unit of the polyglycolic acid. Further, as the dehydration ring-closure catalyst, for example, a tertiary amine such as pyridine, trimethylpyridine, dimethylpyridine or triethylamine can be used, but it is not limited thereto. The amount of the dehydration ring-closing oxidizing agent is preferably 0.01 to 10 moles per mole of the dehydrating agent used. The organic solvent used in the dehydration ring-closure reaction may, for example, be an organic solvent exemplified as a solvent used in the synthesis of polyglycolic acid. Further, the reaction temperature of the dehydration ring closure reaction is preferably from 0 to 180 ° C, more preferably from 10 to 150 ° C. The reaction time is preferably from 0.5 to 30 hours, more preferably from 2 to 10 hours. The quinone imidized polymer obtained in the above method (I) may be directly supplied to a liquid crystal alignment agent, or may be obtained by refining the obtained quinone imidized polymer and then supplying it to a liquid crystal alignment agent. Further, in the above method -31-200948861 (II), a reaction solution containing a ruthenium iodide polymer is obtained. The reverse can be directly supplied to the preparation of the liquid crystal alignment agent, or the liquid crystal can be prepared by removing the dehydrating agent and the dehydration ring-closing catalyst, and the preparation of the supply liquid can be separated after the separation of the ruthenium iodide polymer, or can be separated. The quinone imidized polymer concentrates the formulation of the liquid crystal alignment agent. The dehydrating agent ring catalyst is removed from the reaction solution, and a method such as solvent replacement can be employed. Separation and purification of the quinones can be carried out in the same manner as described above for the polyacetin 0 purification method. The ruthenium iodide polymer used in the present invention may be a complete dehydration ring-closed structure of the valine acid structure of the amine acid, or may be a partial valerate structure dehydration ring closure, a structure and a quinone ring. Coexisting quinone imide. The oxime imidization ratio of the ruthenium iodide polymer is preferably from 1 to 10%, more preferably from 40 to 90%. The "yttrium imidation rate" refers to the enthalpy expressed as a percentage of the quinone imine ring structure relative to the total amount of valeric acid and quinone ring in the polymer. At this time, a part of the quinone ring may also be an imine ring. The ruthenium amination rate can be arbitrarily controlled by adjusting the above-described dehydration ring closure conditions. &lt;Solid viscosity of polyaminic acid and ruthenium iodide&gt; When the polyglycine and the ruthenium iodide polymer used in the present invention are formulated into a solution having a concentration of 10% by weight, preferably 20 The solution viscosity of ~ s is better than the solution viscosity (mPa_s) of the above-mentioned polymer having a solubility of 30 to 500 mPa.s, which is obtained by using the solution and the reaction solution to the compounding agent of the agent. Separation of dehydrated amylation polymerization, pro-polymerization of polyamidated proline sulphate ~100%, the so-called structure quantity ratio is used as the inverse of the isoindole reaction, when respectively -8 0 0 m P a * e viscosity. Polymer -32- 200948861 Good solvent (such as N-methyl-2-pyrrolidone, butyrolactone, etc.) formulated as a 〇 〇 weight % polymer solution, measured with an E-type rotary viscometer at 25 ° C Hey. &lt;Other Ingredients&gt; The liquid crystal alignment agent of the present invention comprises at least one polymer selected from the group consisting of a specific polyamic acid and a quinone imidized polymer as described above without impairing the effects of the present invention. Other ingredients may optionally be included on the premise of the advantages. Examples of such other components include a compound having at least one epoxy group in the molecule (hereinafter referred to as "epoxy compound"), a functional decane compound, and the like. For example, ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1 , 6-hexanediol diglycidyl ether, glycerol diglycidyl charm, 2,2-dibromo neopentyl glycol diglycidyl ether, \:^"', :^'-tetraglycidyl-m-phenylene Methylamine, 1,3-bis(1^,;^-dihydrogen glycerylaminomethyl)cyclohexane, N,N,N',N'·tetraglycidyl·4,4′- Aminodiphenylmethane, anthracene, hydrazine-diglycidyl-benzylamine, hydrazine, hydrazine-diglycidyl-aminomethylcyclohexane, etc. The mixing ratio of these epoxy compounds is relative to 100 The part by weight of the polymer is preferably 40 parts by weight or less, more preferably 0.1 to 30 parts by weight. The decane compound may, for example, be 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, 2-aminopropyltrimethoxydecane or 2-aminopropyltriethoxylate. Decane, Ν-(2·aminoethyl)-3-aminopropyltrimethoxydecane, Ν-(2-aminoethyl)-3-aminopropyl-33- 200948861 methyldimethoxy Baseline, 3-ureidopropyltrimethoxydecane, 3-ureidopropyltriethoxydecane, N-ethoxycarbonyl-3-aminopropyltrimethoxydecane, N-ethoxycarbonyl-3 -Aminopropyltriethoxydecane, N-triethoxydecylpropyltriethylamine, N-trimethoxydecylpropyltriethylamine, 10-trimethoxydecane -1,4,7-triazadecane, 10-triethoxydecyl-1,4,7-triazadecane, 9-trimethoxydecyl-3,6-diazaindole Acetate, 9-triethoxydecyl-3,6-diazadecyl acetate, methyl 9-trimethoxydecyl-3,6-diazadecanoate, 9-three Ethoxy decyl hydrazine - methyl 3,6-diazepine, N-benzyl-3.aminopropyltrimethoxydecane, N-benzyl-3-aminopropyltriethoxy矽Alkane, N-phenyl-3-aminopropyltrimethoxydecane, N-phenyl-3-aminopropyltriethoxydecane, glycidoxymethyltrimethoxydecane, propylene-propylene Oxymethyltriethoxydecane, 2-glycidoxyethyltrimethoxydecane, 2-glycidoxyethyltriethoxydecane, 3-glycidoxypropyltrimethoxy A decyl alkane, a 3-glycidoxypropyltriethoxy decane, etc. The mixing ratio of these functional decane compounds is preferably 2 parts by weight or less based on 100 parts by weight of the polymer, more preferably The liquid crystal alignment agent of the present invention is preferably obtained by dissolving the above-mentioned polymer and optionally other components in an organic solvent. The organic solvent which can be used in the liquid crystal alignment agent of the present invention may, for example, be a solvent exemplified as a solvent used in the synthesis reaction of polyglycine. It is also possible to appropriately select a solvent which is exemplified as a poor solvent which can be used in the synthesis reaction of polyproline. -34- 200948861 A particularly preferred organic solvent which can be used in the liquid crystal alignment agent of the present invention is, for example, N-methyl-2-pyrrolidone, r-butyrolactone, r-butyrolactone, hydrazine, hydrazine-II. Methylformamide, N,N-dimethylacetamide, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol monomethyl ether, butyl lactate, butyl acetate, methoxypropyl Methyl ester, ethyl ethoxypropionate, ethylene glycol methyl ether, ethylene glycol ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether (butyl cellosolve), ethylene glycol Dimethyl ether, ethylene glycol ethyl ether acetate, diglyme, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, Diethylene glycol monoethyl ether acetate, isoamyl propionate, isoamyl isobutyrate, isoamyl ether, ethylene carbonate, propylene carbonate, and the like. They may be used singly or in combination of two or more. A particularly preferable solvent composition is a composition obtained by combining the above solvents, and is a composition in which the polymer does not precipitate from the alignment agent and the surface tension of the alignment agent falls within the range of 25 to 40 mN/m. The solid content concentration of the liquid crystal alignment agent of the present invention (the ratio of the total weight of the components other than the solvent in the liquid crystal alignment agent to the total weight of the liquid crystal alignment agent) Q is selected in consideration of viscosity, volatility, and the like. It is preferably from 1 to 10% by weight. That is, the liquid crystal alignment agent of the present invention forms a coating film as a liquid crystal alignment film by applying it to the surface of the substrate and then removing the solvent, and when the solid content concentration is less than 1% by weight, the coating film is caused. If the thickness exceeds 4, it is difficult to obtain a good liquid crystal alignment film, and when the solid content concentration exceeds 10% by weight, the thickness of the coating film is too thick and it is also difficult to obtain a good liquid crystal alignment film, and the liquid crystal alignment agent may be sticky. The increase in the properties leads to a deterioration in coating performance, and thus is not preferable. The particularly preferable solid content concentration range differs depending on the method used to apply the liquid crystal alignment agent to the -35-200948861 substrate. For example, when the spin coating method is employed, it is preferably 1.5 to 4.5 weight%. The scope. When the printing method is employed, it is preferable that the solid content concentration is in the range of 3 to 9 % by weight, so that the viscosity of the solution falls within the range of 12 to 50 rnPa's. When the ink jet method is employed, it is preferable that the solid content concentration is in the range of 1 to 5% by weight, so that the solution viscosity falls within the range of 3 to 15 mPa's. The temperature at which the liquid crystal alignment agent of the present invention is formulated is preferably 〇 ° C to 200 ° C, more preferably 20 ° C to 60 ° C. <Liquid crystal display element> The liquid crystal display element of the present invention has a liquid crystal alignment film formed of the liquid crystal alignment agent of the present invention as described above. The liquid crystal display element of the present invention can be produced, for example, by the following methods (1) to (3). (1) The liquid crystal alignment agent of the present invention is applied to a transparent conductive film provided with a substrate on which a patterned transparent conductive film is formed by an appropriate coating method such as a roll coating method, a spin coating method, a printing method, or an inkjet method. On one side, a coating film is formed by heating the coating surface. As the substrate, for example, glass such as float glass or soda lime glass, polyethylene terephthalate, polybutylene terephthalate, polyether maple, polycarbonate, or polycyclic ring can be used. A transparent substrate made of plastic such as olefin). As the transparent conductive film, a NESA film made of Sn02, an ITO film made of ln203-Sn02, or the like can be used. For forming the patterned transparent conductive film, a method of forming a pattern by photolithography after forming a transparent conductive film without patterning, and forming a pattern directly by using a mask having a desired pattern when the transparent conductive film is formed may be employed. A method of forming a transparent conductive film or the like. -36- 200948861 In the application of the liquid crystal alignment agent, in order to further improve the adhesion between the substrate and the transparent conductive film and the coating film, a functional decane compound, titanate, or the like may be previously coated on the substrate and the transparent conductive film. . The heating temperature after the application of the liquid crystal alignment agent is preferably 80 to 300 ° C, more preferably 120 to 250 ° C. The heating time is preferably from 5 to 200 minutes, more preferably from 10 to 100 minutes. The liquid crystal alignment agent of the present invention forms a coating film as a liquid crystal alignment film by coating the organic solvent as described above, and when the polymer contained in the liquid crystal alignment agent of the present invention is a poly-proline or a φ is present When the imine-imided polymer of the imine ring structure and the proline structure is formed, it is also possible to carry out a dehydration ring-closure reaction by further heating after forming a coating film to form a coating film which is further imidized. The thickness of the formed coating film is preferably 0.001 to 1 mm, more preferably 0.005 to 0.5/zm, as the thickness after solvent removal. In addition, when the liquid crystal display element to which the liquid crystal alignment agent of the present invention is applied is a VA type liquid crystal display element, a projecting structure can be formed on the substrate as described in, for example, JP-A-2002-327058. The liquid crystal alignment agent is applied afterwards to achieve the purpose of improving the viewing angle performance. (2) The coating film formed as described above may be used as the liquid crystal alignment film of the VA liquid crystal display element as it is, or may be subjected to the following polishing treatment as needed. When the coating film is used as a liquid crystal alignment film of a TN type or STN type liquid crystal display element, the surface of the coating film formed as described above is fixed by a roll wrapped with a cloth made of a fiber such as nylon, rayon, or cotton. Grinding treatment of direction friction. Thus, the coating film is imparted with the alignment energy of the liquid crystal molecules to form a liquid crystal alignment film. By the liquid crystal alignment film formed as described above, the ultraviolet light is partially irradiated as shown in the patent document No. 37-200948861, for example, the patent document 15 (Japanese Patent Laid-Open Publication No. H22366) or the patent document 16 (JP-A-6-2 81937). In the process of changing the pretilt angle, or after partially forming a resist film on the surface of the liquid crystal alignment film which has been subjected to the rubbing treatment as shown in the patent document 17 (Japanese Laid-Open Patent Publication No. H5-107544), After the polishing process is performed in different directions, the resist film is removed, so that the liquid crystal alignment of the liquid crystal alignment film can be changed, and the field of view of the liquid crystal display element can be improved. b - 〇 (3) Two pieces of liquid crystal are formed as described above. The substrate of the alignment film is placed opposite to each other through a gap (cell gap). The peripheral portions of the two substrates are bonded together with a sealant, and liquid crystal is injected into the cell gap surrounded by the surface of the substrate and the sealant, and the injection holes are closed to constitute a liquid crystal cell. Then, a polarizing plate was provided on each of the outer surfaces of the liquid crystal cells, i.e., on the transparent substrate side of both, to obtain a liquid crystal display element. Here, as the sealant, for example, an epoxy resin or the like containing alumina balls as a curing agent and a separator can be used. Examples of the liquid crystal include nematic liquid crystals and dish-shaped liquid crystals, of which Ο is preferably a nematic liquid crystal, and for example, a Schiff's-type liquid crystal, an oxidized azo-based liquid crystal, a biphenyl-based liquid crystal, or a phenyl ring can be used. A hexane liquid crystal, an ester liquid crystal, a terphenyl liquid crystal, a biphenyl cyclohexane liquid crystal, a pyrimidine liquid crystal, a dioxane liquid crystal, a bicyclooctane liquid crystal, or a cuba liquid crystal. Further, in these liquid crystals, cholesteric liquid crystals such as cholesteryl cholesteryl, cholesteryl phthalate, and cholesteryl carbonate may be added under the trade names "C-1 5" and "CB-15" (manufactured by Merck & Co., Inc.). The sale is performed on the palm and the like. The polarizing plate to be bonded to the outer surface of the liquid crystal may be a polarizing film called "ruthenium film" which is obtained by stretching and dispersing polyvinyl alcohol and simultaneously absorbing iodine - 38- « 200948861 A polarizing plate, or a polarizing plate made of a ruthenium film itself. EXAMPLES Hereinafter, the present invention will be more specifically illustrated by the examples, but the present invention is not limited to the examples. The solution viscosity of the polymer and the ruthenium iodide ratio of the ruthenium iodide polymer in the following synthesis examples were evaluated by the following methods. [Solid viscosity of the polymer] 溶液 The solution viscosity (mPa·s) of the polymer was measured at 25 ° C for each polymer solution using a Ε-type rotational viscometer. [The ruthenium imine ratio of the ruthenium iodide polymer] The ruthenium iodide polymer is dried under reduced pressure at room temperature, and then dissolved in deuterated dimethyl hydrazine, using tetramethyl decane as a reference. The W-NMR measured at room temperature was determined by the following formula (i). Ruthenium amination rate (%) = (1 - A^A^cOxlOO (i) A1: peak area from the NH matrix near 10 ppm Ο A2: peak area from other protons α: relative to 醯The ratio of the number of other nh protons in the imidized polymer precursor (polyproline), the number of other protons. Synthesis Example 1 (synthesis of hydrazide polymer Α1) will be used as tetracarboxylic dianhydride 3,5,6-tricarboxy-2-carboxymethylnorbornyl-2:3,5:6-dianhydride 1258 (0.50 mol), 147 g of the compound represented by the above formula (^-1) as a diamine (0.24 mol), p-phenylenediamine 26 g (0.24 mol) and 3,5-aminobenzoic acid gallstones vinegar 10.4 g (〇.〇2 mol) dissolved in 1230 g N-methyl-2 In pyrrolidone, the reaction is carried out at 60 ° C for 6 hours. The poly-proline acid solution obtained by adding -39-200948861 is added to N-methyl-2-pyrrolidone to form a polyglycine concentration of 1 〇. The solution viscosity of the % solution was determined to be 50 mP a·s. Then, 190 g of r-butyrolactone was added to the obtained polyamid acid solution, and then 80 g of pyridine and 1 g of acetic anhydride were added. Dehydration ring closure reaction at °C for 4 hours. Thereafter, by replacing the solvent in the system with a new r-butyrolactone solvent (in this operation, the pyridine and acetic anhydride used in the dehydration ring-closure reaction were removed to the outside of the system), about 1 900 g of 15% by weight of hydrazine was obtained. A solution of the imidized polymer A1 having an imidization ratio of about 80%. ❹ A small amount of the solution is diluted with 7&quot;-butyrolactone to form a solution having a concentration of 10% by weight of the ruthenium iodide polymer. The measured solution viscosity was 40 mP as. Synthesis Examples 2 to 8, Comparative Synthesis Examples 1 to 6 (synthesis of ruthenium iodide polymers A2 to A8 and comparative ruthenium iodide polymers R1 to R6) In the same manner as in the above Synthesis Example 1, except that the diamine and the tetracarboxylic dianhydride were listed in the same manner as in the above, the ruthenium-containing polymer A2 to A8 and the comparative ruthenium-based polymer R1 were respectively obtained. The solution of the arsenazolylized polymer was listed in Table 1. In addition, in Table 1, "Compound A" and "Compound B" refer to the above formula (A). a compound and a compound represented by the above formula (B), and the abbreviations of the respective compounds mean the following meanings, respectively The unit of the "amount" of the compound is Mohr. In Comparative Synthesis Examples 1 to 6, two other diamines are used in each case. &lt;Diamine&gt; [Compound represented by the above formula (A)] bl: Cholesteryl 3,5-diaminobenzoate b2: 1-cholestyloxy-2,4-diaminobenzene-40- 200948861 [Compound represented by the above formula (B)] b3 : Compound b4 represented by the formula (B-2): the compound b5 represented by the above formula (B-2): the compound b6 represented by the above formula (B-3): the compound b7 represented by the above formula (B-7): the above formula (B) - the compound b8 represented by the above formula (B-11): the compound represented by the above formula (B-17) ❹ blO : the compound represented by the above formula (B-21) [other diamine] bll: 1-octadecyloxy-2,4-diaminobenzene bl2: p-phenylenediamine &lt;tetracarboxylic dianhydride&gt; al : 3,5,6-tricarboxy-2-carboxymethylnorbornane - 2:3,5:6-dianhydride a2: 2,3,5-tricarboxycyclopentyl acetic acid dianhydride

-41 - 200948861 表1 二胺 四羧酸 二酐 醯亞胺化聚合物 化合物(Α) 化合物(B) 其他二胺 名稱 酸亞胺化率 (%) 觀量) 麵(量) 種類(量) 麵(量) 合成例1 bl(0.02) b3(0.24) bl2(0.24) al(0.5) A1 80 合成例2 bl(0.02) b4(0.24) bl2(0.24) al(0.5) A2 75 合成例3 b 1(0.02) b5(0.24) bl2(0.24) al(0_5) A3 78 合成例4 bl(0.02) b6(0.24) bl 2(0.24) al(0.5) A4 77 合成例5 bl(0.02) b7(0.24) bl 2(0.24) al(0.5) A5 85 合成例ό b2(0.03) b8(0.23) bl2(0_24) a2(0.5) A6 84 合成例7 b2(0.01) b9(0.09) bl2(0.4) al(0.5) A7 80 合成例8 b2(0.01) bl0(0.09) bl2(0.4) a2(0.5) A8 85 比較合成例1 — b3(0.2) bll(O.l) bl2(0.2) al(0.5) R1 85 比較合成例2 — b4(0.2) bll(O.l) bl2(0.2) al(0.5) R2 81 比較合成例3 — b5(0.2) bll(O.l) bl2(0.2) al(0.5) R3 83 比較合成例4 — b6(0.2) bll(O.l) bl2(0.2) al(0.5) R4 78 比較合成例5 — b7(0.2) bll(O.l) bl2(0.2) al(0.5) R5 79 比較合成例6 — b8(0.2) bll(O.l) bl2(0.2) al(0.5) R6 77 ❹ 實施例1 ❹ &lt;液晶配向劑的配製&gt; 向上述合成例1中製得的含有醯亞胺化聚合物A1的溶 液中,相對於100重量份上述聚合物溶液中所含的醯亞胺 化聚合物A1,加入5重量份1,3-二(N,N-二縮水甘油基胺 基甲基)環己烷作爲環氧基化合物,再加入r-丁內酯、N-甲基-2-吡咯烷酮和丁基溶纖劑,配成溶劑組成爲 r-丁內 酯:N-甲基-2-吡咯烷酮:丁基溶纖劑=71 : 17: 12(重量 比)、固體含量濃度爲4重量%的溶液。將該溶液用孔徑爲 -42- 200948861 l#m的過濾器過濾,配製出液晶配向劑。 採用該液晶配向劑,如下進行各種評價。 &lt;印刷性評價&gt; 採用液晶配向膜印刷機(日本寫真印刷(股)製造),將以 上配製的液晶配向劑塗敷在帶有以100 間隔形成了厚 度爲200 nm、寬度爲20# m的條帶狀ITO膜的透明電極的 玻璃基板的透明電極面上,通過在8〇°C下加熱1分鐘形成 塗膜。對該塗膜用20倍倍率的光學顯微鏡進行觀察時’基 〇 板的級差部位被一致地覆蓋,塗膜上沒有觀察到缺陷’印 刷性良好。 &lt;液晶胞的製造&gt; 採用旋塗法將以上配製的液晶配向劑塗敷在帶有ITO 膜製透明電極的玻璃基板的透明電極面上,然後在的 加熱板上加熱1分鐘後,再在2 0 0 °C的加熱板上加熱10分 鐘,形成平均厚度爲6 00 A的塗膜。採用裝有纏繞人造纖維 布的輥的打磨機,在輥轉速爲5 00 rpm、操作臺移動速度爲 ❹ 3cm/秒,絨毛擠入長度爲0.4mm的條件下,對該塗膜進行 打磨處理,賦予塗膜以液晶配向能。然後,將具有該塗膜 的基板在超純水中用超聲波洗滌1分鐘,再在100°C的潔 淨烘箱中乾燥10分鐘,得到透明電極上具有液晶配向膜的 基板。重複該操作,製作一對(兩塊)在透明電極面上具有 液晶配向膜的基板。 然後,在上述一對基板的具有液晶配向膜的各外緣 上,塗敷加入了直徑爲5.5/zm的氧化鋁球的環氧樹脂黏合 劑後,使液晶配向膜面相對向地重合並壓合,再使黏合劑 -43- 200948861 固化。接著,通過液晶注入口向一對基板間塡充向列型液 晶(默克公司製,MLC-6221)後,用丙烯酸系光硬化黏合劑 將液晶注入口封閉,製造出液晶胞。 &lt;預傾角的測定&gt; 按照非專利文獻 1(T. J. Scheffer 等,J· Appl. Phys., 第19卷’ 2013(1980))中記載的方法,通過使用He— Ne雷 射的結晶旋轉法,對以上製造的液晶胞測定預傾角,其預 傾角爲5°,顯示出很高的値》 〇 實施例2〜8和比較例1〜6 除了所用的聚合物溶液中所含的聚合物種類如表2中 所示以外,與上述實施例1同樣地配製液晶配向劑,並進 行評價。評價結果列於表2。 另外,在表2中的比較例1〜6的印刷性評價中,所有 的基板的級差部位均發生了液體凹陷,因而存在沒有形成 塗膜的部分,故其各自的印刷性均判定爲“不良”。 〇 -44- .200948861 表2 液體配向劑 液晶胞 聚合物種類 印刷性 預傾角 實施例1 A 1 良好 5° 實施例2 A2 良好 5。 實施例3 A3 良好 6° 實施例4 A4 良好 5° 實施例5 A5 良好 6° 實施例6 A6 良好 7° 實施例7 A7 良好 6。 實施例8 A8 良好 6° 比較例1 R1 不合格 5。 比較例2 R2 不合格 4° 比較例3 R3 不合格 5。 比較例4 R4 不合格 5° 比較例5 R5 不合格 6° 比較例6 R6 不合格 5° 由以上實施例可知,包含用含有上述式(A)表示的化合 物和上述式(B)表示的化合物的二胺合成的聚合物的本發 明液晶配向劑,顯示出優良的印刷性’並且,所形成的液 晶配向膜顯示出高的預傾角(實施例1〜8)。另一方面,在 使用1-十八烷氧基-2,4-二胺基苯代替上述式(A)表示的化 合物的比較例1〜6中,液晶配向劑的印刷性均獲得很差的 結果。 【圖式簡單說明】 無。 【主要元件符號說明】 無。 -45--41 - 200948861 Table 1 Diamine tetracarboxylic acid dianhydride hydrazide polymer compound (Α) Compound (B) Other diamine name acid imidization ratio (%) Observation amount Surface (quantity) Type (quantity) Surface (quantity) Synthesis Example 1 bl (0.02) b3 (0.24) bl2 (0.24) al (0.5) A1 80 Synthesis Example 2 bl (0.02) b4 (0.24) bl2 (0.24) al (0.5) A2 75 Synthesis Example 3 b 1(0.02) b5(0.24) bl2(0.24) al(0_5) A3 78 Synthesis Example 4 bl(0.02) b6(0.24) bl 2(0.24) al(0.5) A4 77 Synthesis Example 5 bl(0.02) b7(0.24 ) bl 2(0.24) al(0.5) A5 85 Synthesis Example ό b2(0.03) b8(0.23) bl2(0_24) a2(0.5) A6 84 Synthesis Example 7 b2(0.01) b9(0.09) bl2(0.4) al( 0.5) A7 80 Synthesis Example 8 b2(0.01) bl0(0.09) bl2(0.4) a2(0.5) A8 85 Comparative Synthesis Example 1 - b3(0.2) bll(Ol) bl2(0.2) al(0.5) R1 85 Comparative Synthesis Example 2 - b4(0.2) bll(Ol) bl2(0.2) al(0.5) R2 81 Comparative Synthesis Example 3 - b5(0.2) bll(Ol) bl2(0.2) al(0.5) R3 83 Comparative Synthesis Example 4 - b6 (0.2) bll(Ol) bl2(0.2) al(0.5) R4 78 Comparative Synthesis Example 5 - b7(0.2) bll(Ol) bl2(0.2) al(0.5) R5 79 Comparative Synthesis Example 6 - b8(0.2) bll (Ol) bl2(0.2) al(0.5) R6 77 实施 Example 1 ❹ &lt;Preparation of Liquid Crystal Aligning Agent&gt; To a solution containing ruthenium iodide polymer A1 prepared in the above Synthesis Example 1, relative to 100 parts by weight of the ruthenium iodide polymerization contained in the above polymer solution A1, adding 5 parts by weight of 1,3-bis(N,N-diglycidylaminomethyl)cyclohexane as an epoxy compound, and then adding r-butyrolactone, N-methyl-2- Pyrrolidone and butyl cellosolve were formulated to have a solvent composition of r-butyrolactone: N-methyl-2-pyrrolidone: butyl cellosolve = 71: 17: 12 (by weight), and a solid content concentration of 4% by weight. This solution was filtered through a filter having a pore diameter of -42 to 200948861 l#m to prepare a liquid crystal alignment agent. Various evaluations were carried out as follows using this liquid crystal alignment agent. &lt;Printability Evaluation&gt; The liquid crystal alignment agent prepared above was applied with a thickness of 200 nm and a width of 20# m at intervals of 100 using a liquid crystal alignment film printer (manufactured by Japan Photo Printing Co., Ltd.). The transparent electrode surface of the glass substrate of the transparent electrode of the strip-shaped ITO film was formed by heating at 8 ° C for 1 minute to form a coating film. When the coating film was observed with an optical microscope at a magnification of 20 times, the stepped portions of the base plate were uniformly covered, and no defects were observed on the coating film, and the printing property was good. &lt;Production of Liquid Crystal Cell&gt; The liquid crystal alignment agent prepared above was applied onto the transparent electrode surface of a glass substrate made of a transparent electrode made of an ITO film by spin coating, and then heated on a hot plate for 1 minute, and then The film was heated on a hot plate at 200 ° C for 10 minutes to form a coating film having an average thickness of 600 A. The coating film is polished by a grinding machine equipped with a roller wound with a rayon cloth at a roller speed of 500 rpm, a table moving speed of ❹ 3 cm/sec, and a fluffing length of 0.4 mm. The coating film is given a liquid crystal alignment energy. Then, the substrate having the coating film was ultrasonically washed in ultrapure water for 1 minute, and then dried in a 100 ° C clean oven for 10 minutes to obtain a substrate having a liquid crystal alignment film on the transparent electrode. This operation was repeated to fabricate a pair of (two pieces) substrates having a liquid crystal alignment film on the surface of the transparent electrode. Then, on each of the outer edges of the pair of substrates having the liquid crystal alignment film, an epoxy resin adhesive having an alumina ball having a diameter of 5.5/zm is applied, and then the liquid crystal alignment film faces are relatively pressed and pressed together. And then make the adhesive -43- 200948861 cure. Then, a nematic liquid crystal (MLC-6221, manufactured by Merck & Co., Inc.) was charged between a pair of substrates through a liquid crystal injection port, and then the liquid crystal injection port was sealed with an acrylic photocurable adhesive to produce a liquid crystal cell. &lt;Measurement of Pretilt Angle&gt; According to the method described in Non-Patent Document 1 (TJ Scheffer et al., J. Appl. Phys., Vol. 19 '2013 (1980)), a crystal rotation method using He-Ne laser The pretilt angle was measured for the liquid crystal cell manufactured above, and the pretilt angle was 5°, which showed a high 値 〇 〇 Examples 2 to 8 and Comparative Examples 1 to 6 except for the type of the polymer contained in the polymer solution used. As shown in Table 2, a liquid crystal alignment agent was prepared and evaluated in the same manner as in the above Example 1. The evaluation results are shown in Table 2. Further, in the evaluation of the printability of Comparative Examples 1 to 6 in Table 2, since the liquid depression occurred in the step portions of all the substrates, the portion where the coating film was not formed was present, and the printability of each of the substrates was judged as " bad". 〇 -44- .200948861 Table 2 Liquid alignment agent Liquid crystal cell Polymer type Printability Pretilt angle Example 1 A 1 Good 5° Example 2 A2 Good 5. Example 3 A3 Good 6° Example 4 A4 Good 5° Example 5 A5 Good 6° Example 6 A6 Good 7° Example 7 A7 Good 6. Example 8 A8 is good 6° Comparative Example 1 R1 failed 5 . Comparative Example 2 R2 failed 4° Comparative Example 3 R3 failed 5 Comparative Example 4 R4 failed 5° Comparative Example 5 R5 failed 6° Comparative Example 6 R6 Unsatisfied 5° It is understood from the above examples that the compound represented by the above formula (A) and the compound represented by the above formula (B) are contained. The liquid crystal alignment agent of the present invention which is a diamine-synthesized polymer exhibits excellent printability' and the formed liquid crystal alignment film exhibits a high pretilt angle (Examples 1 to 8). On the other hand, in Comparative Examples 1 to 6 in which 1-octadecyloxy-2,4-diaminobenzene was used in place of the compound represented by the above formula (A), the printability of the liquid crystal alignment agent was poorly obtained. result. [Simple description of the diagram] None. [Main component symbol description] None. -45-

Claims (1)

200948861 七、申請專利範圍: 1. 一種液晶配向劑,其特徵在於包括從下述群組中選出的 至少一種聚合物’該群組由聚醯胺酸以及將該聚醯胺酸 脫水閉環而製得的醯亞胺化聚合物構成,該聚醯胺酸由 二胺與四羧酸二酐反應所製得,該二胺含有下述式(A) 表示的化合物和下述式(B)表示的化合物,200948861 VII. Patent application scope: 1. A liquid crystal alignment agent characterized by comprising at least one polymer selected from the group consisting of polylysine and dehydration of the polyglycolic acid. A ruthenium-imided polymer obtained by reacting a diamine with a tetracarboxylic dianhydride containing a compound represented by the following formula (A) and expressing the following formula (B) compound of, 式(A)中,A1表示單鍵、亞甲基、碳原子數爲2〜12的伸 烷基、氟代亞甲基或碳原子數爲2〜6的氟代伸烷基,A2 表示-0-、-COO-、-OCO-、-NHCO-、-CONH-或-CO-,A3 表示具有甾體骨架的1價有機基團,In the formula (A), A1 represents a single bond, a methylene group, an alkylene group having 2 to 12 carbon atoms, a fluoromethylene group or a fluoroalkylene group having 2 to 6 carbon atoms, and A2 represents - 0-, -COO-, -OCO-, -NHCO-, -CONH- or -CO-, A3 represents a monovalent organic group having a steroid skeleton, 式(B)中,B1 爲- 0-、-COO·、-OOC-、-CONH-或-NHCO-, B2爲聯苯基;氰基聯苯基;氟代聯苯基;具有碳原子數 爲1〜32的烷基的(烷基環己基)苯基;具有碳原子數爲1 〜32的烷氧基的烷氧基苄基、二烷氧基苯基或烷氧基聯 苯基;具有碳原子數爲1〜32的氟代烷氧基的氟代烷氧 基聯苯基;或者碳原子數爲1〜32的烷基,bl和b3各 -46- .200948861 自爲〇或1,b2爲2〜22的整數。 2.如申請專利範圍第丨項所述的液晶配向劑,其 胺中的上述式(A)表示的化合物的比例爲〇.1、 %。 3 .如申請專利範圍第1或2項所述的液晶配向劑 述式(A)表示的化合物爲由膽甾烯氧基_2, 苯、3,5-二胺基苯甲酸膽甾烯基酯、膽甾烷 二胺基苯和3,5·二胺基苯甲酸膽甾烷基酯構成 _ 選出的至少一種。 4. 一種液晶顯示元件,其特徵在於具有由如申請 第1至3項中任一項所述的液晶配向劑形成的 膜。 ❹ 中上述二 - 50莫耳 ,其中上 4-二胺基 氧基-2,4- 的群組中 專利範圍 液晶配向 -47- 200948861 四、指定代表圖: (一) 本案指定代表圖為:無。 (二) 本代表圖之元件符號簡單說明: te 〇 jw\ 五、本案若有化學式時,請揭示最能顯示發明特徵的化學式:In the formula (B), B1 is -0-, -COO., -OOC-, -CONH- or -NHCO-, B2 is a biphenyl group; a cyanobiphenyl group; a fluorobiphenyl group; having a carbon number An (alkylcyclohexyl)phenyl group having 1 to 32 alkyl groups; an alkoxybenzyl group having a carbon number of 1 to 32, a dialkoxyphenyl group or an alkoxybiphenyl group; a fluoroalkoxybiphenyl having a fluoroalkoxy group having 1 to 32 carbon atoms; or an alkyl group having 1 to 32 carbon atoms, bl and b3 each -46-.200948861 , b2 is an integer of 2 to 22. 2. The liquid crystal alignment agent according to the above aspect of the invention, wherein the ratio of the compound represented by the above formula (A) in the amine is 0.1%. 3. The liquid crystal alignment agent according to claim 1 or 2, wherein the compound represented by the formula (A) is cholesteneoxy-2, benzene, cholesteryl 3,5-diaminobenzoic acid The ester, the cholestanediamine benzene, and the cholesteryl 3,5-diaminobenzoate constitute at least one selected. A liquid crystal display element comprising a film formed of the liquid crystal alignment agent according to any one of claims 1 to 3. ❹ The above two - 50 moles, of which the upper 4-diaminooxy-2,4- group of patents range liquid crystal alignment -47- 200948861 IV. Designated representative map: (1) The representative representative of the case is: no. (2) A brief description of the symbol of the representative figure: te 〇 jw\ 5. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention:
TW098109439A 2008-03-25 2009-03-24 Liquid crystal aligning agent and liquid crystal display element TWI453234B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008079142A JP5099346B2 (en) 2008-03-25 2008-03-25 Liquid crystal aligning agent and liquid crystal display element

Publications (2)

Publication Number Publication Date
TW200948861A true TW200948861A (en) 2009-12-01
TWI453234B TWI453234B (en) 2014-09-21

Family

ID=41192216

Family Applications (1)

Application Number Title Priority Date Filing Date
TW098109439A TWI453234B (en) 2008-03-25 2009-03-24 Liquid crystal aligning agent and liquid crystal display element

Country Status (4)

Country Link
JP (1) JP5099346B2 (en)
KR (1) KR101520972B1 (en)
CN (1) CN101544827B (en)
TW (1) TWI453234B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011209505A (en) * 2010-03-30 2011-10-20 Jnc Corp Liquid crystal aligning agent, liquid crystal alignment layer, and liquid crystal display element

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3097702B2 (en) * 1991-08-13 2000-10-10 日産化学工業株式会社 New liquid crystal alignment agent
JP4196527B2 (en) * 2000-06-30 2008-12-17 コニカミノルタホールディングス株式会社 Liquid crystal display element
TWI291065B (en) * 2000-12-26 2007-12-11 Nissan Chemical Ind Ltd Diamines, polyimide precursors and polyimides produced by using the diamines, and liquid crystal aligning agents
JPWO2002051908A1 (en) * 2000-12-26 2004-04-22 日産化学工業株式会社 Diaminobenzene derivative, polyimide precursor and polyimide using the same, and liquid crystal alignment treatment agent
JP4600637B2 (en) * 2002-04-30 2010-12-15 Jsr株式会社 Liquid crystal alignment agent
JP4524569B2 (en) * 2004-03-10 2010-08-18 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
JP4968422B2 (en) * 2004-12-15 2012-07-04 Jsr株式会社 Method for producing liquid crystal alignment film
KR101359106B1 (en) * 2006-04-25 2014-02-05 제이에스알 가부시끼가이샤 Vertical alignment type liquid crystal aligning agent and vertical alignment type liquid crystal display

Also Published As

Publication number Publication date
KR20090102665A (en) 2009-09-30
CN101544827A (en) 2009-09-30
KR101520972B1 (en) 2015-05-15
JP2009236959A (en) 2009-10-15
JP5099346B2 (en) 2012-12-19
CN101544827B (en) 2013-12-18
TWI453234B (en) 2014-09-21

Similar Documents

Publication Publication Date Title
TWI356068B (en) Liquid crystal alignment agent and liquid crystal
TWI356934B (en) Liquid crystal alignment agent and liquid crystal
TWI432484B (en) Liquid crystal alignment agent and liquid crystal display element
TWI447144B (en) Liquid crystal alignment agent and liquid crystal display element
TWI447145B (en) Liquid crystal alignment agent and liquid crystal display element
TWI386434B (en) Liquid crystal orientation agent and liquid crystal display element
TWI476489B (en) Liquid crystal aligning agent and liquid crystal display element
TWI468813B (en) Liquid crystal aligning agent and liquid crystal display element
TWI461802B (en) Liquid crystal aligning agent and liquid crystal display element
TWI381041B (en) Liquid crystal alignment agent and liquid crystal display element
TWI416227B (en) Liquid crystal alignment and transverse type liquid crystal display element
TW200811553A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI445736B (en) Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element
TWI427103B (en) Liquid crystal aligning agent and liquid crystal display element
TWI501011B (en) Liquid crystal aligning agent and liquid crystal display element
TWI460210B (en) Liquid crystal alignment agent and liquid crystal display element
TWI444727B (en) Liquid crystal alignment agent and liquid crystal display element
TW201003254A (en) Liquid crystal aligning agent, liquid crystal display element, polyamic acid, polyimide and compound
TWI428370B (en) Liquid crystal aligning agent and liquid crystal display element
TW200932787A (en) Liquid crystal aligning agent and liquid crystal display element
TW200804519A (en) Liquid crystal alignment agent for ink-jet coating and liquid crystal display device
TWI466921B (en) Vertical alignment type liquid crystal aligning agent and vertical alignment type liquid crystal display element
TW200819510A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI354843B (en) Liquid crystal alignment agent and liquid crystal
TW200932789A (en) Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element